- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 22.12.2023
- Impfdatum
- 11.11.2022
- Beginn
- 18.10.2023
- Tage bis Beginn
- 341,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abdominal pain
Acute respiratory failure
Asthenia
Blood urea increased
Bronchial wall thickening
COVID-19
COVID-19 pneumonia
Chest discomfort
Computerised tomogram thorax abnormal
Cough
Diarrhoea
Dyspnoea
Glomerular filtration rate decreased
Haemoptysis
Hyperlipidaemia
Hypertension
Hypoxia
Influenza like illness
Symptomtext
Patient is a pleasant 77-year-old male presented to the emergency department a chief complaint of flulike symptoms including cough, fever, myalgias, chest tightness, abdominal pain, diarrhea that been ongoing since 10/15/2023. Patient reports that his wife is at home and has been diagnosed with COVID-19, currently on Paxlovid. Patient reports he has been increasingly short of breath, a productive cough of sputum that has been blood-tinged but is noted to be minimal. He has taken Tessalon Perles and coughing has ceased. Patient reports that he is normally very active, but is increasingly weak but denies any falls or trauma. Sinus sitting at bedside and states that the whole family was camping last weekend, and he had felt ill a few days ago. Patient also notes that his granddaughter was found to be positive for strep throat within the last week. Denies any tobacco, alcohol illicit drug use. Denies any chronic cardiovascular or pulmonary conditions. He denies any lightheadedness, dizziness, nausea/vomiting, melena, or hematochezia. Work-up in the ED: As above patient to be positive for COVID-19 pneumonia and exhibited hypoxia with ambulation down to 85%. Currently on 2 L nasal cannula to maintain oxygen saturation above 90%. Was given loading dose of Decadron, ceftriaxone, and azithromycin in the ED. Patient is noted to have slight worsening of renal function with GFR 53, CRT 1.37, and BUN 23, but does not meet criteria for AKI. CT findings as above. At this current time patient is hemodynamically stable and will be admitted under the hospitalist service for further work-up continuation of care. Clinical Summary Patient was admitted to the medical surgical unit due to acute hypoxic respiratory failure secondary to COVID-19 infection with probable pneumonitis with evidence of tracheal wall thickening and thickening of the mainstem bronchi. Patient had no reoccurrence of hemoptysis. He was placed on remdesivir and dexamethasone. The following morning patient was feeling significantly improved, no longer requiring oxygen and requesting discharge. I personally ambulated the patient in the room and he had no SPO2 less than 90% with ambulation and conversation. Discussed Paxlovid with patient who wished to proceed with therapy. Medications were reviewed and patient was instructed to stop his statin until completion of Paxlovid. He was also given steroid and short course antibiotic related to the tracheal inflammation. I have asked that he follow-up with pulmonology in regards to the CT findings of tracheal wall and maintenance stem bronchi thickening which may warrant biopsy in the future. He did have some mild to moderate thrombocytopenia likely related to COVID. I have asked him to recheck lab works in 1 week. Discharge diagnosis Acute hypoxic respiratory failure, secondary to COVID-19 pneumonitis without consolidating pneumonia Hemoptysis Hypertension Hyperlipidemia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 90,0
- Geschlecht
- F
- Eingang
- 03.12.2022
- Impfdatum
- 14.11.2022
- Beginn
- 25.11.2022
- Tage bis Beginn
- 11,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute myocardial infarction
Anticoagulant therapy
Asthenia
Cardiac failure
Diuretic therapy
Dyspnoea
Prohormone brain natriuretic peptide increased
Troponin increased
Symptomtext
11/25 Patient was admitted to the ER/hospital with SOB and weakness that occurred 3 days prior. Patient was hospitalized for NSTEMI (med managed because pt sustained GI bleed from heparin drip so unable to go to angiogram) and Heart failure (diuresed).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- -
- Labordaten
- Pro BNP 5,762 Trop 43, 41
- Aktuelle Erkrankungen
- Small bowel obstruction and hospitalization one month prior.
- Vorgeschichte
- Afib, DM2, hyponatremia, hyperkalemia, Chronic Kidney disease stage 3, Hypertension, Hyperlipidemia, GERD, essential tremor, depression,Heart failure with preserved EF and anxiety.
- Andere Medikamente
- -
- Allergien
- No Known allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 28.11.2022
- Impfdatum
- 28.10.2021
- Beginn
- 20.11.2021
- Tage bis Beginn
- 23,0
- Dosis
- 4
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Angiogram
Blood test
Cerebrovascular accident
Computerised tomogram
Magnetic resonance imaging
Parainfluenzae virus infection
Urinary tract infection
Symptomtext
I had my vaccination on 10/28/2022. I had a stroke on 11/20/21. I was sent to the ER where they performed a CAT scan MRI blood panel and angio. I was admitted to the hospital for 4 days. I was also diagnosed with Parainfluenza virus type 3 with symptoms appearing 7 days prior with a UTI.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cerebrovascular accident
- Hospital-Tage
- 4,0
- Labordaten
- 11/20/2021 CAT scan MRI blood panel and angio
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- WELLBUTRIN; BRILINTA; aspirin
- Allergien
- CELEBREX; penicillin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 06.06.2023
- Impfdatum
- 14.12.2022
- Beginn
- 24.04.2023
- Tage bis Beginn
- 131,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiogenic shock
Hypotension
Symptomtext
I95.9 HYPOTENSION 4/24/2023 CARDIOGENIC SHOCK R57.0 CARDIOGENIC SHOCK 4/24/2023 CARDIOGENIC SHOCK
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiogenic shock
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 04.04.2023
- Impfdatum
- 18.10.2022
- Beginn
- 06.02.2023
- Tage bis Beginn
- 111,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Anticoagulant therapy
Blood magnesium
Blood pressure decreased
Blood test
Brain natriuretic peptide
Chest X-ray
Computerised tomogram
Computerised tomogram head
Computerised tomogram neck
Computerised tomogram thorax
Differential white blood cell count
Echocardiogram
Electrocardiogram
Femur fracture
Foot fracture
Full blood count
Influenza virus test
Loss of consciousness
Symptomtext
2/6/2023 passed out, broke a chip off femur and big toe. BP dropped when sitting or standing. Went to ER and admitted to the hospital for 8 days. Doctors double checked pacemaker. Ran an EKG with 12 leads, did a CT scan of brain, neck, chest, both knees, and both feet. Did CBC with differential, full blood work up, Troponin, Full Metabolic panel. X ray of both knees, 2/7 magnesium, Troponin; BNP or ProBNP, Chest x ray, left wrist, right toes. X-ray of femur; 2/8 CVC with differential; Ultrasound Doppler of both legs. 2/9 Echocardiogram 2/10 Ultrasound of right leg and groin; 2/14 right foot x ray, flu/RSV/COVID-19 panel; 2/16 teomery report. Participant developed blood clot and is now on blood thinners.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- 8,0
- Labordaten
- Ran an EKG with 12 leads, did a CT scan of brain, neck, chest, both knees, and both feet. Did CBC with differential, full blood work up, Troponin, Full Metabolic panel. X ray of both knees, 2/7 magnesium, Troponin; BNP or ProBNP, Chest x ray, left wrist, right toes. X-ray of femur; 2/8 CVC with differential; Ultrasound Doppler of both legs. 2/9 Echocardiogram 2/10 Ultrasound of right leg and groin; 2/14 right foot x ray, flu/RSV/COVID-19 panel; 2/16 teomery report.
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Pacemaker
- Andere Medikamente
- Multivitamin; probiotic; simvastatin; calcium; vitamin D; cyclosporine eyedrops; lubricating eyedrop; REFRESH ointment PM; fluticasone
- Allergien
- Sulfa; codeine; hydrocodone; oral KEFLEX
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 84,0
- Geschlecht
- F
- Eingang
- 15.03.2023
- Impfdatum
- 21.10.2022
- Beginn
- 15.03.2023
- Tage bis Beginn
- 145,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cardiac failure
Cardiogenic shock
Computerised tomogram head normal
Endotracheal intubation
General physical health deterioration
Mental status changes
Mitral valve incompetence
Symptomtext
Patient is an 84yo female with extensive PMH as listed above who presented to the ED due to AMS with question of stroke v. Seizure activity. Patient was intubated on arrival for airway protection. Patient has no new stroke findings on CTH. Still question of seizure activity with unknown etiology. Neurology consult in ED suggested correlation with stroke HX. Question of infectious process as well with acute hypoxic respiratory failure after just having COVID v. Cardiogenic shock form CHF (congestive heart failure) with recently found severe reduced EF of 26%, PH, severe MR. Patient's declining status could be multifactorial.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cardiogenic shock
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 28.12.2022
- Impfdatum
- 03.11.2022
- Beginn
- 08.11.2022
- Tage bis Beginn
- 5,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Anaemia
Blood test
Computerised tomogram head
Condition aggravated
Essential hypertension
Computerised tomogram
Inflammation
Laboratory test
Magnetic resonance imaging
Muscle spasms
Hypoaesthesia
Musculoskeletal disorder
Paraesthesia
Muscular weakness
Paralysis
Sensory loss
Walking aid user
Reflexes abnormal
Symptomtext
Started having weakness in both legs and muscle cramps on 11-8-22. Then tingling in hands and feet which moved up her extremities. She saw her PCP on 11-11-22, Dr for a regular visit and reported her symptoms. Pt does not have insurance until 1-1-2023. Since Dr retired, she went to the Community Health and saw, FNP on 12-2-22. Was told if her symptoms worsened then she should go the the ER. On 12-7-22, she went to the ER and a CAT scan was done. On 12-11-22, she was admitted to Hospital and was in-patient until the 17th. She saw a neurologist, Dr and ortho, Dr from hospital. She received a week of IV steroids. She presently is using a walker to walk and still does not have feeling in limbs. She was told this was a spinal inflammation and she also has partial paralysis in her torso. MRI and labs were done. She stated the MS was ruled out. She is waiting until she has insurance beginning 1-1-2023 to get second opinions and do more follow-up. She stated she has never had any type of reaction to any vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paralysis
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension Diabetes
- Andere Medikamente
- Lorsatan, Paxil 20 mg, Metformin 500mg bid, Multi-vitamin
- Allergien
- Zithromax
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 23.12.2022
- Impfdatum
- 15.12.2022
- Beginn
- 15.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Apnoea
Dizziness
Dyspnoea
Hypotension
Influenza like illness
Loss of consciousness
Nausea
Syncope
Symptomtext
not breathing; Dizziness; nausea; fainted; unconscious; not breathing; Flu like symptoms/ Fever/ joint pain/Her joint pain was excruciating on Friday evening in her hips, and both shoulder joints/ swelling over her body; low blood pressure; This spontaneous case was reported by an other health care professional and describes the occurrence of SYNCOPE (fainted), LOSS OF CONSCIOUSNESS (unconscious) and APNOEA (not breathing) in a 71-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Co-suspect products included non-company products GABAPENTIN for an unknown indication, CODEINE PHOSPHATE, PARACETAMOL (TYLENOL WITH CODEINE) for an unknown indication and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for an unknown indication. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine. Concurrent medical conditions included Mast cell activation syndrome, Food allergy (Severe allergic to corn and corn products.), Pollen allergy and Allergy to chemicals. On 15-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient started GABAPENTIN (unknown route) 600 milligram, CODEINE PHOSPHATE, PARACETAMOL (TYLENOL WITH CODEINE) (unknown route) 600 milligram and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) (unknown route) 1 dosage form. On 15-Dec-2022, the patient experienced SYNCOPE (fainted) (seriousness criterion medically significant), LOSS OF CONSCIOUSNESS (unconscious) (seriousness criterion medically significant), APNOEA (not breathing) (seriousness criterion medically significant), INFLUENZA LIKE ILLNESS (Flu like symptoms/ Fever/ joint pain/Her joint pain was excruciating on Friday evening in her hips, and both shoulder joints/ swelling over her body), HYPOTENSION (low blood pressure), DIZZINESS (Dizziness) and NAUSEA (nausea). On an unknown date, the patient experienced DYSPNOEA (not breathing). At the time of the report, SYNCOPE (fainted), LOSS OF CONSCIOUSNESS (unconscious), APNOEA (not breathing), INFLUENZA LIKE ILLNESS (Flu like symptoms/ Fever/ joint pain/Her joint pain was excruciating on Friday evening in her hips, and both shoulder joints/ swelling over her body), HYPOTENSION (low blood pressure), DIZZINESS (Dizziness) and NAUSEA (nausea) had not resolved and DYSPNOEA (not breathing) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments. Concomitant and treatment medications were not reported. Company Comment This spontaneous case concerns a 71-years-old female patient, with medical history of Mast cell activation syndrome, food, chemical, and pollen allergy, severely allergic to Corn and all corn products. previously administered Moderna COVID-19 Vaccine, without adverse events, co-suspect products GABAPENTIN; TYLENOL WITH CODEINE and DIPHENHYDRAMINE who experienced the unexpected seriousness criterion medically significant events of syncope, loss of consciousness and apnoea; the unexpected events of influenza like illness, hypotension, dyspnoea and other expected events beginning the same day after a dose of mRNA- 1273 bivalent vaccine. The medical history of Mast cell activation syndrome is a confounder for the event nausea; the co-suspect medication of GABAPENTIN is a contributor for influenza like illness of pyrexia, the events dizziness, apnoea, dispnoea and nausea; TYLENOL WITH CODEINE for the events hypotension, influenza like illness symptom sweating, events nausea, dizziness, dyspnoea and apnoea. The benefit-risk relationship of mRNA-1273 bivalent vaccine is not affected by this report. Events seriousness was assessed based on medical judgement.; Sender's Comments: Company Comment This spontaneous case concerns a 71-years-old female patient, with medical history of Mast cell activation syndrome, food, chemical, and pollen allergy, severely allergic to Corn and all corn products. previously administered Moderna COVID-19 Vaccine, without adverse events, co-suspect products GABAPENTIN; TYLENOL WITH CODEINE and DIPHENHYDRAMINE who experienced the unexpected seriousness criterion medically significant events of syncope, loss of consciousness and apnoea; the unexpected events of influenza like illness, hypotension, dyspnoea and other expected events beginning the same day after a dose of mRNA- 1273 bivalent vaccine. The medical history of Mast cell activation syndrome is a confounder for the event nausea; the co-suspect medication of GABAPENTIN is a contributor for influenza like illness of pyrexia, the events dizziness, apnoea, dispnoea and nausea; TYLENOL WITH CODEINE for the events hypotension, influenza like illness symptom sweating, events nausea, dizziness, dyspnoea and apnoea. The benefit-risk relationship of mRNA-1273 bivalent vaccine is not affected by this report. Events seriousness was assessed based on medical judgement.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy to chemicals; Food allergy (Severe allergic to corn and corn products.); Mast cell activation syndrome; Pollen allergy
- Vorgeschichte
- -
- Andere Medikamente
- GABAPENTIN, TYLENOL WITH CODEINE, BENADRYL A
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 19.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 5
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthropathy
Asthenia
Body temperature increased
Laboratory test
Pain
Syncope
Symptomtext
fainted but was still awake; loads of pain in my hands and knees; really weak; This spontaneous case was reported by a patient and describes the occurrence of SYNCOPE (fainted but was still awake) in a 78-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. In 2022, the patient experienced SYNCOPE (fainted but was still awake) (seriousness criterion medically significant), PAIN (loads of pain in my hands and knees) and ASTHENIA (really weak). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency. In 2022, PAIN (loads of pain in my hands and knees) was resolving. At the time of the report, SYNCOPE (fainted but was still awake) and ASTHENIA (really weak) outcome was unknown. Patient has received first dose of the Moderna COVID-19 vaccine by intramuscular injection on 19Jan2021, lot number 013L20A, second dose on 16Feb2021, lot number 010M20A, Third dose on 21Nov2021, lot number 010A21A, Fourth dose on 13May2022, lot number 004M21A. No concomitant medications was provided. Patient took another Advil which helped for 1.5 days. Patient has not had any pain in his knees like before. Patient went to the emergency room 10 days ago. Company comment: This spontaneous case concerns a 78-year-old male patient with no medical history reported, who experienced the unexpected serious (medically significant) event of Syncope that occurred unknown days after receiving mRNA-1273 Bivalent BA.4/BA.5 vaccine(fifth dose) in COVID-19 vaccination series. Latency could not be assessed as the exact onset date of the event was not available. Patient experienced pain in his knees and hands. No further information regarding risk factors, clinical course, medical history, concurrent conditions, investigations and treatment received were provided. The outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 is not affected by this report. This case was linked to US-MODERNATX, INC.-MOD-2022-682327 (Patient Link).; Sender's Comments: This spontaneous case concerns a 78-year-old male patient with no medical history reported, who experienced the unexpected serious (medically significant) event of Syncope that occurred unknown days after receiving mRNA-1273 Bivalent BA.4/BA.5 vaccine(fifth dose) in COVID-19 vaccination series. Latency could not be assessed as the exact onset date of the event was not available. Patient experienced pain in his knees and hands. No further information regarding risk factors, clinical course, medical history, concurrent conditions, investigations and treatment received were provided. The outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 19.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthropathy
Asthenia
Body temperature increased
Laboratory test
Pain
Syncope
Symptomtext
fainted but was still awake; loads of pain in my hands and knees; really weak; This spontaneous case was reported by a patient and describes the occurrence of SYNCOPE (fainted but was still awake) in a 78-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. In 2022, the patient experienced SYNCOPE (fainted but was still awake) (seriousness criterion medically significant), PAIN (loads of pain in my hands and knees) and ASTHENIA (really weak). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency. In 2022, PAIN (loads of pain in my hands and knees) was resolving. At the time of the report, SYNCOPE (fainted but was still awake) and ASTHENIA (really weak) outcome was unknown. Patient has received first dose of the Moderna COVID-19 vaccine by intramuscular injection on 19Jan2021, lot number 013L20A, second dose on 16Feb2021, lot number 010M20A, Third dose on 21Nov2021, lot number 010A21A, Fourth dose on 13May2022, lot number 004M21A. No concomitant medications was provided. Patient took another Advil which helped for 1.5 days. Patient has not had any pain in his knees like before. Patient went to the emergency room 10 days ago. Company comment: This spontaneous case concerns a 78-year-old male patient with no medical history reported, who experienced the unexpected serious (medically significant) event of Syncope that occurred unknown days after receiving mRNA-1273 Bivalent BA.4/BA.5 vaccine(fifth dose) in COVID-19 vaccination series. Latency could not be assessed as the exact onset date of the event was not available. Patient experienced pain in his knees and hands. No further information regarding risk factors, clinical course, medical history, concurrent conditions, investigations and treatment received were provided. The outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 is not affected by this report. This case was linked to US-MODERNATX, INC.-MOD-2022-682327 (Patient Link).; Sender's Comments: This spontaneous case concerns a 78-year-old male patient with no medical history reported, who experienced the unexpected serious (medically significant) event of Syncope that occurred unknown days after receiving mRNA-1273 Bivalent BA.4/BA.5 vaccine(fifth dose) in COVID-19 vaccination series. Latency could not be assessed as the exact onset date of the event was not available. Patient experienced pain in his knees and hands. No further information regarding risk factors, clinical course, medical history, concurrent conditions, investigations and treatment received were provided. The outcome of the event was unknown. The benefit-risk relationship of mRNA-1273 Bivalent BA.4/BA.5 is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 05.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site pain
Syncope
Unresponsive to stimuli
Symptomtext
Site: Pain at Injection Site-Mild, Systemic: Fainting / Unresponsive-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 04.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Flushing
Hyperhidrosis
Mydriasis
Syncope
Tremor
Unresponsive to stimuli
Symptomtext
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: mydriasis for about 10 seconds-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Loss of consciousness
Symptomtext
Systemic: Fainting / Unresponsive-Severe, Additional Details: patient passed out for few minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 22.10.2022
- Impfdatum
- 18.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Feeling hot
Flushing
Hyperhidrosis
Immediate post-injection reaction
Presyncope
Symptomtext
Systemic: Flushed / Sweating-Severe, Additional Details: sweating, felt so hot immediately after the vaccine, and almost faint
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 16.10.2022
- Impfdatum
- 16.10.2022
- Beginn
- 16.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Seizure
Symptomtext
patient had seizure and lightheadedness. she was waiting outside to get air before paramedic came. Drank a pedialyte. Paramedic came and took her to hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- N/A
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 31.07.2023
- Impfdatum
- 28.10.2022
- Beginn
- 14.02.2023
- Tage bis Beginn
- 109,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypertension
Hypotension
Symptomtext
HYPOTENSION 4/17/2023 HTN (HYPERTENSION)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 27.06.2023
- Impfdatum
- 17.10.2022
- Beginn
- 01.06.2023
- Tage bis Beginn
- 227,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exercise tolerance decreased
Injection site pain
Mobility decreased
Symptomtext
PATIENT BEGAN EXPERIENCING ARM PAIN RECENTLY (SPECIFIC TIME UNKNOWN) NEAR THE SITE OF MODERNA INJECTION RECEIVED 10/17/22. HIS PAIN FEELS DEEP IN THE ARM AND HAS PROGRESSIVELY GOTTEN WORSE, WITH SEVERE PAIN AT NIGHT. AT TIMES HE HAS TROUBLE LIFTING HIS ARM ABOVE HIS HEAD. HE DOES NOT RECALL ANY UNUSUAL/SEVERE PAIN SHORTLY AFTER THE INJECTION, AND ALSO RECEIVED FLUZONE HD IN THE OTHER ARM WITH NO ISSUES. THERE ISN'T AND WAS NEVER A BRUISE OR LUMP AT THE SITE. HE DOES LIFT ARM WEIGHTS ON A DAILY BASIS AND ONLY STOPPED FOR A COUPLE DAYS AFTER THE INJECTION.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- LEVOTHYROXINE, ROSUVASTATIN, LISINOPRIL, TAMSULOSIN
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 09.06.2023
- Impfdatum
- 28.10.2022
- Beginn
- 05.06.2023
- Tage bis Beginn
- 220,0
- Dosis
- 5
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal pain lower
Alanine aminotransferase normal
Ammonia
Anion gap
Aspartate aminotransferase normal
Asthenia
Auscultation
Back pain
Bacterial test positive
Basophil count decreased
Basophil percentage decreased
Bilirubin urine
Blood albumin normal
Blood alkaline phosphatase normal
Blood bilirubin increased
Blood calcium normal
Blood chloride normal
Blood creatine phosphokinase normal
Symptomtext
Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on June 05, 2023 21:34 Verified By: MD on June 05, 2023 21:34 Encounter Info: Hospital, Inpatient, 06/05/23 - * Final Report * Document Has Been Revised History of Present Illness/Subjective Chief complaint: Generalized weakness History of present illness: 82-year-old female with past medical history of hypertension, diabetes mellitus, hyperlipidemia presented with generalized weakness. Family is at bedside assisting with history Patient is fairly active for her age, she works in the garden and is very independent of her ADLs. She was doing fine until the last 2 days when she started to have generalized weakness. Initially she had headache and neck pain and then felt very weak and was not able to walk. Today when family came from outside the found her sitting in the chair and was not able to move or use the bathroom. She was wearing a diaper which is very unusual for her. Patient complains of lower abdominal pain, low back pain without any radiation. This is better now She denies shortness of breath or cough. No fever or chills No vomiting or diarrhea She denies dysuria but has some urgency and frequency In the ED, she was given amlodipine 5 mg for uncontrolled hypertension and ceftriaxone Review of Systems Pertinent positives/negatives as noted in HPI. All other systems were reviewed and are negative. Physical Exam/Objective Vitals & Measurements most recent past 24 hours Hemodynamics Neurologic Patient Weight Patient Height None Reported 06/05/23 16:48 (L) 36.1 DegC 75 bpm 15 br/min 97 % 4 (H) 157 mmHg 67 mmHg 97 mmHg 55 kg Stand up General: Alert, in no acute cardiopulmonary distress. Mental Status: Oriented to person, place and time. Normal affect. Head: Normocephalic. Eyes: Pupils are equal, round and reactive to light. Extraocular muscles intact. Throat: Oropharynx clear, mucous membranes moist. Neck: Supple, Full range of motion. Respiratory: Clear to auscultation and percussion. No wheezing, rales or rhonchi. Cardiovascular: Heart sounds normal. No thrills. Regular rate and rhythm, no murmurs, rubs or gallops. Gastrointestinal: Abdomen soft, non-tender, non-distended. Normal bowel sounds. No pulsatile mass. No hepatosplenomegaly. Genitourinary: No costovertebral angle tenderness. Neurologic: Cranial nerves II-XII grossly intact. No focal neurological deficits. Deep tendon reflexes +2 bilaterally. Flexor plantar response. Moves all extremities spontaneously. Sensation intact bilaterally. Skin: No rashes or lesions. No petechiae or purpura. No edema. Musculoskeletal: No cyanosis or clubbing. No gross deformities. Normal range of motion. Assessment/Plan 82-year-old female with past medical history of hypertension, diabetes mellitus, hyperlipidemia presented with generalized weakness 1. Generalized weakness R53.1 PT/OT -Likely from UTI -Check TSH and B12 -COVID-19 is pending -CT head showed generalized cerebral atrophy without acute intracranial abnormality ? Chest x-ray showed no acute findings ? CT abdomen/pelvis showed no acute findings, liver hemangiomas, proximal SMA atherosclerotic narrowing, mild fatty liver -Her weakness is more in the lower legs but she does not have any weakness in the upper extremities or facial droop/dysphagia or dysarthria. We will hold off on MRI of the brain. She denies having any trauma to her back. Denies any fall 2. Acute UTI N39.0 UA showed WBC of 21-50 and moderate leukocyte esterase -Continue ceftriaxone and follow urine cultures 3. Leukocytosis D72.829 Leukocytosis with WBC of 12.6. Patient does not have sepsis. No tachycardia or tachypnea -Chest x-ray and CT abdomen/pelvis showed no acute issues 4. Chronic kidney disease (CKD) N18.9 stage 3. Baseline creatinine is less than 1. Monitor 5. Diabetes mellitus E11.9 Hold metformin due to recent contrast exposure and start on low sliding scale insulin. Her A1c's have been less than 7 6. Gastroesophageal reflux disease K21.9 Awaiting reconciliation. Plan to continue Protonix 7. Hypertension I10 On hydralazine as needed. She received amlodipine 5 mg in ED 8. Liver hemangioma D18.03 Noted and stable from previous CT scans 9. Hyperlipidemia E78.5 On statin 10. On deep vein thrombosis (DVT) prophylaxis Z79.899 On Lovenox Orders: Status Order Acknowledgement Code Status None Recorded Chronic Problem List Anxiety Atrophic vaginitis B12 deficiency Chronic kidney disease (CKD) Cognitive decline Dementia Diabetes mellitus Encounter for vitamin deficiency screening Encounter for vitamin deficiency screening Foot pain, left Gastroesophageal reflux disease Hypertension Hypokalemia Insomnia Liver hemangioma Long term use of drug Annual wellness visit, subsequent Pain of left lower leg Procedure/Surgical History ?Diabetic retinal eye exam (11/22/2021) ?colonoscopy (10/12/2016) ?CT of abdomen and pelvis (10/19/2015) ?Appendectomy ?Cesarean section ?Cystocele ?Hysterectomy Surgical History Internal 10/12/2016 Colonscpy Diagnostic/Screen MD Medications Home Medications (12) Active amLODIPine 5 mg oral tablet 5 mg = 1 Tablet, Orally, BID Blood Glucose Test Strips See Instructions, Test Blood Sugar once a day Dx: DM E11.9 Claritin 10 mg oral tablet 10 mg, Orally, Daily lancets See Instructions, use to test blood sugar once daily.Dx: E11.9 Lancets See Instructions, use to check blood sugar once dailywhat brand ins covers dx E11.9 Melatonin 10 mg, Orally, At Bedtime metFORMIN 500 mg oral tablet 500 mg = 1 Tablet, Orally, BID multivitamin , Orally, Daily pravastatin 40 mg oral tablet 40 mg = 1 Tablet, Orally, At Bedtime Protonix 40 mg oral delayed release tablet 40 mg = 1 Tablet, Orally, Daily Strips - Glucose Test See Instructions, use to check blood sugar once daily dx: E11.9 Systane Ultra Preservative Free 1 Drop, Eyes, Both, BID Active Scheduled Inpatient Medications None Reported One-Time Medications Given 06/04/23 00:00:00 TO 06/05/23 21:32:05 None Reported PRN Medications (0600 - 0559) from 06/04 - 06/05 None Reported Allergies Centrum Silver (unknown) Fish (unknown) Premarin (unknown) Tagamet (unknown) aspirin (unknown) penicillins (unknown) terfenadine derivatives (unknown) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Asthma: Mother. Depression: Sister. Diabetes...: Father. Heart disease..: Grandmother (M). Hypertension..: Father. Stroke: Grandmother (M). Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 12.6 k/cumm High (06/05/23 18:04:00) RBC: 4.75 million/cumm (06/05/23 18:04:00) Hgb: 13.4 GM/dL (06/05/23 18:04:00) Hct: 40.7 % (06/05/23 18:04:00) MCV: 86 fL (06/05/23 18:04:00) MCH: 28.3 pg (06/05/23 18:04:00) MCHC: 33 GM/dL (06/05/23 18:04:00) RDW: 14.6 % High (06/05/23 18:04:00) Platelet: 395 k/cumm (06/05/23 18:04:00) MPV: 7.6 fL (06/05/23 18:04:00) Neutrophils %: 83 % (06/05/23 18:04:00) Lymphocytes %: 8 % (06/05/23 18:04:00) Monocytes %: 10 % (06/05/23 18:04:00) Eosinophils %: 0 % (06/05/23 18:04:00) Basophils %: 0 % (06/05/23 18:04:00) Absolute Neutrophil: 10.4 k/cumm High (06/05/23 18:04:00) Absolute Lymphocyte: 0.9 k/cumm Low (06/05/23 18:04:00) Absolute Monocyte: 1.2 k/cumm (06/05/23 18:04:00) Absolute Eosinophil: 0 k/cumm (06/05/23 18:04:00) Absolute Basophil: 0 k/cumm (06/05/23 18:04:00) Chemistry: Sodium SerPl QN: 138 mmol/L (06/05/23 18:04:00) Potassium SerPl QN: 3.6 mmol/L (06/05/23 18:04:00) Chloride SerPl QN: 101 mmol/L (06/05/23 18:04:00) Carbon Dioxide SerPl QN: 22 mmol/L (06/05/23 18:04:00) Anion Gap: 15 mmol/L High (06/05/23 18:04:00) BUN SerPl QN: 30 mg/dL High (06/05/23 18:04:00) Creatinine SerPl QN: 0.92 mg/dL (06/05/23 18:04:00) Estimated GFR (CKD-EPI, no race): 62 mL/min/1.73m2 (06/05/23 18:04:00) Estimated CRCL (CG): 41 mL/min Low (06/05/23 18:04:00) Glucose SerPl QN: 169 mg/dL High (06/05/23 18:04:00) Calcium Total SerPl QN: 10.1 mg/dL (06/05/23 18:04:00) Alkaline Phos SerPl QN: 66 Units/L (06/05/23 18:04:00) ALT SerPl QN: 12 Units/L (06/05/23 18:04:00) AST SerPl QN: 15 Units/L (06/05/23 18:04:00) Bilirubin Total SerPl QN: 1.2 mg/dL High (06/05/23 18:04:00) Total Protein SerPl QN: 8.2 GM/dL High (06/05/23 18:04:00) Albumin SerPl QN: 4.4 GM/dL (06/05/23 18:04:00) CK SerPl QN: 124 Units/L (06/05/23 18:04:00) Troponin-I High Sensitivity: 10 ng/L (06/05/23 18:04:00) BNP Pl QN: 67 pg/mL (06/05/23 18:04:00) Ammonia Pl QN: 32 mCmol/L (06/05/23 18:04:00) Lactate Venous Pl QN: 1.4 mmol/L (06/05/23 18:04:00) Coagulation: PT: 13.1 seconds (06/05/23 18:04:00) INR: 1.14 (06/05/23 18:04:00) Urine Studies: Color: Yellow (06/05/23 18:33:00) Clarity: Slightly Cloudy (06/05/23 18:33:00) Specific Gravity: 1.027 (06/05/23 18:33:00) pH: 5.5 (06/05/23 18:33:00) Protein: 200 Abnormal (06/05/23 18:33:00) Glucose: 50 Abnormal (06/05/23 18:33:00) Ketones: 20 Abnormal (06/05/23 18:33:00) Bilirubin: NEGATIVE (06/05/23 18:33:00) Hgb Ur: Small 1+ Abnormal (06/05/23 18:33:00) Nitrite: NEGATIVE (06/05/23 18:33:00) Urobilinogen: Normal (06/05/23 18:33:00) Leukocyte Esterase Ur: Moderate250 Abnormal (06/05/23 18:33:00) WBC: 21-50 Abnormal (06/05/23 18:33:00) RBC: 6-10 Abnormal (06/05/23 18:33:00) Bacteria: TRACE. (06/05/23 18:33:00) Yeast Ur: PRESENT. Abnormal (06/05/23 18:33:00) Squamous Epithelial: Few (06/05/23 18:33:00) Mucous: PRESENT. (06/05/23 18:33:00) Diagnostics Radiology Results - Last 24 hours Across Visits 06/05/2023 18:08 - XR Chest PA or AP Portable IMPRESSION:1. No acute findings in the chest.Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us with any questions. 06/05/2023 19:58 - CT Abd/Pelvis W/IV Contrast IMPRESSION:1. No acute findings in the abdomen or pelvis.2. Multiple hypoechoic liver lesions are similar to decreased insize from the patient's prior study and are compatible withhemangiomas.3. Mild to moderate atherosclerotic narrowing of the proximal SMAfor 2.5 cm.4. Mild fatty liver.Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us with any questions. 06/05/2023 19:58 - CT Head W/o IV Contrast IMPRESSION: 1. Stable generalized cerebral atrophy without CT evidence of acuteintracranial abnormalities.Thank you for consulting our team of subspecialty radiologists at Radiology. Please contact us with any questions. Signature Line Electronically Signed on 06/05/23 21:34 ________________________________________________________ MD Electronically Signed on 06/05/23 23:19 ________________________________________________________ MD Reviewed by MD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 15.05.2023
- Impfdatum
- 31.10.2022
- Beginn
- 08.12.2022
- Tage bis Beginn
- 38,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Arthritis
Asthma
COVID-19
Condition aggravated
Pain in extremity
Pneumonia
SARS-CoV-2 test positive
Symptomtext
I had a sore arm for about a day after receiving the vaccine. I tested positive for COVID-19 on 12/08/2022. I contacted my doctor and got a prescription for molnupiravir. I tolerated the medication without any complications. Since receiving the vaccine, I have trouble with my arthritis and my asthma. I was diagnosed with pneumonia on 02/04/2023 and was hospitalized for eight days. As of today, I continue to have problems with my asthma.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 8,0
- Labordaten
- 04FEB2023 Pneumonia positive; 08DEC2022 COVID-19 test positive
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Chronic Asthma; Defibrillator; Psoriatic Arthritis
- Andere Medikamente
- N/A
- Allergien
- Seafood; peaches
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 26.04.2023
- Impfdatum
- 23.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram cerebral abnormal
CSF pressure increased
Empty sella syndrome
Eye movement disorder
Intracranial pressure increased
Lumbar puncture abnormal
Magnetic resonance imaging head abnormal
Migraine
Photophobia
Vertigo
Vestibular disorder
Vestibular function test abnormal
Vestibular neuronitis
Symptomtext
The day after I received the fifth vaccine, I developed light sensitive, migraines, vertigo, my eyes were jumping towards my vestibular nerve. I went to the doctor who referred me to a vestibular doctor, he put me through a serious of test where they watched where my eyes went when they do certain things. The test results showed my vestibular nerve had been irritated, and I had vestibular neuritis. I was prescribed two rounds of Methylprednisolone and a high dose of Prednisone, Doxycycline. In November I had and MRI that showed I had a partial empty Sella. I had an appointment with an ophthalmologist who did not find anything with my optic nerve. I had an angiogram that showed increase pressure on my brain. On April 17 I had a lumbar puncture that showed I have an opening pressure of 33. I am on Acetazolamide to help with the increased pressure on my brain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- 00OCT2023 Vestibular testing - positive for vestibular neuritis; 00NOV2023 MRI - positive for partial empty Sella; 09MAR2023 Angiogram - positive for increase pressure on the brain; 17APR2023 - Lumbar Puncture - positive for opening pressure of 33
- Aktuelle Erkrankungen
- Cold
- Vorgeschichte
- No
- Andere Medikamente
- Singulair; Azelastine; Flonase; Alegra
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 24.04.2023
- Impfdatum
- 21.10.2022
- Beginn
- 01.01.2023
- Tage bis Beginn
- 72,0
- Dosis
- 5
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypertension
Symptomtext
I went to my doctor for a routine exam, they noticed my blood pressure was high. She checked it at the end of the exam, it was still high, she prescribed me medication to help bring it down. We have been watching my blood pressure and I have been following up with her every month and my blood pressure is currently back to normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- No
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Long QTS
- Andere Medikamente
- Metoprolol; Crestor; Baby Aspirin
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 19.04.2023
- Impfdatum
- 18.10.2022
- Beginn
- 01.03.2023
- Tage bis Beginn
- 134,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Nerve compression
Pain
Paraesthesia
X-ray limb abnormal
Symptomtext
On March 1, 2023, I was feeling pain in my shoulder. I went to the doctor who performed an exam, I was given meloxicam and cyclobenzaprine. This did not help to alleviate my pain. I went to an osteo doctor to help get the root of the problem. He took an x-ray. The x-ray showed, I had no problems with my bones, no fractures. I had a pinched nerve. He prescribed prednisone and diclofenac to help with the anthric pain and pinched nerve pain. I feel that I am healing, I ache and tingle where before I hurt more than anything.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- 10MAR2023 X-ray - negative for bone problem
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Breast Cancer in 2020 in remission
- Andere Medikamente
- Exemestane; Losartan; Dayvigo; Calcium plus D3; Philips Colon Health; Turmeric plus Cumin; Imiprin
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 17.04.2023
- Impfdatum
- 02.11.2022
- Beginn
- 21.03.2023
- Tage bis Beginn
- 139,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anaemia
COVID-19
Computerised tomogram abnormal
Cough
Dyspnoea
Emphysema
Hilar lymphadenopathy
Hypotension
Hypoxia
Laboratory test normal
Lung neoplasm malignant
Lymphadenopathy mediastinal
Malaise
Metabolic function test normal
Pain
Pulmonary mass
Renal failure
Respiratory tract infection
Symptomtext
Patient is a 86 y.o. female patient of Private MD with a history of breast cancer hypertension was hospitalized in local hospital with cough shortness of breath and found to have COVID-19 infection. She was treated with remdesivir and IV antibiotics she underlying severe emphysema and a CAT scan did show that she has evidence of right lung mass with hilar and mediastinal lymphadenopathy. I suspect primary lung cancer. She does have a history of breast cancer antiemetics but she does need a lung biopsy and I spoke to the patient examined her interviewed her give a copy of the CAT scan I also spoke to alternate Dr. who is his primary care physician also spoke to primary Dr. and the patient renal biopsy but the patient right now does not want to get anything done that she discussed with the family members. Her white count is normal she has mild anemia basic metabolic panel fine was unremarkable. I reviewed the medication. She had renal failure which got better by stopping the lisinopril HCTZ and she is currently being treated supportively with the steroids antibiotic and she is taken off the oxygen. She has finished 3 days of remdesivir currently not on oxygen and she is doing better overall she is pleasant cooperative in stable condition and she is being discharged home in stable condition to her home with the isolation for 10 days total and she will be referred to her primary care physician and alternate Dr. regarding a lung biopsy if she is willing to Acute COVID-19 She had COVID-19 with respiratory infection with hypoxia needing remdesivir and steroids, antibiotics, supportive care, nebulizers, and will need oxygen and hydration. Her blood pressure is low. She has generalized body ache and malaise. We expect her to get better. We will check the labs every day and give her DVT prophylaxis. 3/22/23: She is responding remdesivir steroid and has been getting better and has gotten stronger she is not on oxygen no fever and chills labs were reviewed. She does have a mass in the lung which needs further evaluation. 3/23/23: She has COVID-19 infection she is improving now. She has been off the oxygen lungs are sounding better she has no fever her labs were reviewed and they are unremarkable she is getting better and being discharged home and may need isolation for 10 days total.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 13.04.2023
- Impfdatum
- 28.10.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 5,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Blood test
Computerised tomogram
Giant cell arteritis
Magnetic resonance imaging
Mobility decreased
Pain in extremity
Polymyalgia rheumatica
Ultrasound Doppler
Symptomtext
11/2/2022 my left arm hurt where I had the vaccine. It continued to hurt more and longer than previous shots. Lifting my arm was hard. Within a week to two weeks, my shoulder began to hurt. Then two weeks later my right shoulder hurt and all my joints were very painful. I had never experienced this before. I then went to the emergency room and was given prednisone which helped. After I finished the prednisone, it came back. I followed up with various doctors and was diagnosed with Polymyalgia Rheumatica with Giant Cell Arteritis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- DEC22 does not have the dates, a lot of bloodwork, CT, Dopplers, MRI's; Diagnosed with Polymyalgia Rheumatica with Giant Cell Arteritis.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Inflammatory Disease; Genetic Disorder G2O2NA Blood Clotting Disorder
- Andere Medikamente
- Duloxetine; topiramate; ELIQUIS; atorvastatin; vitamin D; gabapentin; levothyroxine; baby aspirin; pantoprazole
- Allergien
- Ciprofloxacin
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 99,0
- Geschlecht
- F
- Eingang
- 06.04.2023
- Impfdatum
- 21.11.2022
- Beginn
- 21.02.2023
- Tage bis Beginn
- 92,0
- Dosis
- 5
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Atrial fibrillation
COVID-19
Chest X-ray abnormal
Dyspnoea
Hypoxia
Lung opacity
Malaise
SARS-CoV-2 test positive
Tachycardia
Symptomtext
On 2/21/2023, patient presented to the emergency department for evaluation of shortness of breath, malaise, and a positive COVID-19 test at her residential facility on 2/20/2023. In the emergency department, patient was given a COVID-19 antigen test which also resulted positive; Her chest x-ray showed bilateral interstitial opacities, new since 12/4/2022. Patient was afebrile but she was tachycardic and hypoxic; She was diagnosed with COVID-19 and new onset atrial fibrillation. Patient was started on diltiazem drip, IV fluid, given O2 and IV Decadron. However, when goals of care were discussed with the patient, she stated that she did not want aggressive treatment but instead wanted to be transitioned to hospice care. Patient was admitted to the hospital for further care and transition to hospice. Submitter does not have access to further medical information on this case including discharge date. If more information is needed, please contact the admitting hospital: Local Hospital,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 2/20/2023 - positive COVID-19 antigen test at her residential facility 2/21/2023 - In Emergency Department - positive COVID-19 antigen test; Chest x-ray showed bilateral interstitial opacities.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Hypertension, hyperlipidemia, hypothyroidism, Graves? disease, epilepsy, chronic kidney disease, and anxiety.
- Andere Medikamente
- Unknown
- Allergien
- ALLERGIES: Ciprofloxacin - Pt arm turned red with Cipro IV.
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 04.04.2023
- Impfdatum
- 02.11.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Blood glucose normal
Blood test abnormal
Cardiac stress test abnormal
Cardiac valve thickening
Cardiomegaly
Dyspnoea
Echocardiogram abnormal
Mean platelet volume decreased
Symptomtext
I started having issues catching my breath around January 2023. I went to see my doctor around January 15, 2023. I went back 1 week later to have a stress test with Echocardiogram which showed that the was heart enlarged a little bit. The schedule a Cath for 3 weeks out but the symptoms increasingly got worse and became more often. I was advised by my primary care doctor to go to the emergency room. I was admitted for 2 days, and they completed a heart ultrasound and the following day they put in the cath. The ultrasound showed that there was thickening in the right side of the heart. I have been placed on medication and have not had any issues in 6 to 7 weeks. I was prescribed Lipitor and a Baby aspirin once daily.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 2,0
- Labordaten
- Stress Test-January 2023- Echocardiogram with Stress Test-Heart Enlarged-January 23, 2023 Heart Ultrasound-showed that there was thickening in the right side of the heart-2022 Blood panel- MPV low; Glucose 102
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Vitamin B12
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 15.03.2023
- Impfdatum
- 09.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Flushing
Heart rate increased
Malaise
Palpitations
Symptomtext
Patient presents to PCP for routine physical. Patient reports palpitations after COVID booster in 11/22. Noted multiple resting HR in the 140s and one time in the 180s sustained for several minutes at rest. Felt unwell, flushed but no chest pain or SOB, nausea, or dizziness. PCP believes temporally related to COVID shot and recommended avoiding further boosters. Has seemingly resolved and hasn't felt ill since November. Some elevated HR readings on smart watch but patient isn't sure if related to working out or not.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 23.02.2023
- Impfdatum
- 14.10.2022
- Beginn
- 31.01.2023
- Tage bis Beginn
- 109,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Fatigue
Migraine
Pyrexia
SARS-CoV-2 test positive
Upper-airway cough syndrome
Symptomtext
I started out having postnasal drip on January 31. I did take pharmacy sinus congestion PE which didn't help at all. I had a low-grade fever of about 100, lots of fatigue and a migraine. I dealt with this for one day then I took a home test and the results were bright pink stating a positive reading for COVID-19. I then contacted my doctor and was given PAXLOIVD. I'm not sure if the medication worked because all symptoms were gone by the time, I got the script. I am still dealing with the cough maybe from the long-term postnasal drip. If I had to describe this, I would say I had a mild case I just have the cough still. I have been told its common to have this cough.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- COVID-19 at home test
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Prediabetic; Thyroid issues; Colin Cancer
- Andere Medikamente
- Atorvastatin; pregabalin; metformin; levothyroxine
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 09.02.2023
- Impfdatum
- 19.10.2022
- Beginn
- 01.01.2023
- Tage bis Beginn
- 74,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute kidney injury
Aspiration pleural cavity
Blood creatinine increased
COVID-19
Cough
Diarrhoea
Dyspnoea
Hypervolaemia
SARS-CoV-2 test positive
Symptomtext
"Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: ""82-year-old gentleman with past medical history significant for chronic obstructive pulmonary disease, coronary artery disease, CVA, ventricular tachycardia status post ICD, hypertension, OSA on oxygen at night as well as orthostatic hypotension. He presented to the emergency department on 01/01/2023 with a chief complaint of worsening shortness of Breath. Patient was recently in the emergency department and was diagnosed with COVID, he was not hypoxic so he was sent home nebulizers. He states over last couple days his symptoms have gotten progressively worse so they decided to return to the emergency department. Wife and daughter are at bedside. He admits to a cough which is nonproductive. He denies any chest pain, abdominal pain, nausea or vomiting. He does admit to a few episodes of diarrhea this morning. On arrival to the emergency department he was noted to be fluid overloaded as well as COVID positive and was given a dose of Lasix. He will be admitted to the floor for further monitoring. Patient was given a couple doses of lasix with minimal improvement and an increase in his creatinine levels which resulted in patient undergoing a thoracentesis from which he received tremendous benefit. Patient was kept an additional day for observation as he had returned to his baseline O2 requirement of 1-2L NC. The following day patient was discharged after working with therapies. While there was some discussion on possible rehab prior to discharge home, family and patient reported good support at home and deferred option. Patient further continued to have a stable mild AKI with Cr. 1.3 and a repeat BMP for 1 week from discharge was ordered. """
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 3,0
- Labordaten
- Covid PCR detected on 12/29/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Cardiovascular Carotid Artery Stenosis HTN (hypertension) with recent hypotension PVD (Peripheral Vascular Disease) Subclavian Artery Stenosis Orthostatic hypotension - Vasopressor Type Syncope Syndrome Ventricular ectopy Orthostatic lightheadedness with related gait issues Renal artery stenosis (HCC) Coronary artery disease involving native coronary artery Ventricular tachycardia Nonrheumatic mitral valve regurgitation Acute on chronic heart failure (HCC) with mildly reduced EF - 45-50% Digestive Dysphagia with aspiration risk Respiratory Recurrent left pleural effusion - transudative - requiring repeat thoracenteses now status post tunneled pleural catheter Chronic respiratory insufficiency COPD with emphysema (HCC) Chronic sinusitis Sinus headache OSA (obstructive sleep apnea) Sinusitis, chronic Urinary Urinary retention Other History of multiple lacunar strokes Dependence on nicotine from cigarettes Cachexia (HCC) FH: CAD (coronary artery disease) Hearing loss Headache Encounter for screening for lung cancer ICD (implantable cardioverter-defibrillator) in place COVID-19 Folic acid deficiency Severe protein-calorie malnutrition (HCC) History of COVID-19 pneumonia - + test on 12/29/22 Failure to thrive in adult Unintentional weight loss
- Andere Medikamente
- albuterol 5 mg/mL nebu 2.5 mg, sodium chloride 0.9 % nebu 3 mL Take 2.5 mg by nebulization every 4 (four) hours as needed (shortness of breath and wheezing). Indications: shortness of breath and wheezing albuterol sulfate (ProAir RespiClic
- Allergien
- BananaSwelling Pcn [Penicillins]Hives Sulfa (Sulfonamide Antibiotics)Hives
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 25.01.2023
- Impfdatum
- 25.10.2022
- Beginn
- 01.01.2023
- Tage bis Beginn
- 68,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Hypertension
Pain
Pyrexia
Symptomtext
After vaccine, I got fever, body ache, but suddenly my joints hurt, I had pain and then my blood pressure was high, I monitored 3 times a day, I went to the doctor and prescribed medication, I have been monitoring it and call the doctor with results. Now is 130/135 but before it was over 200. It was very alarming; I am now taking 4 pills daily.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Arthritis; Mild Headaches
- Andere Medikamente
- SYNTHROID; NORVASC; BYSTOLIC; CYMBALTA; NEXIUM; multivitamin; vitamin D3; calcium; vitamin B12
- Allergien
- Penicillin
- Vorherige Impfungen
- Shingles, 2nd dose, 75-year-old; fever, body aches, arm hurt & red from shoulder to elbow.
- Staat
- WI
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 24.01.2023
- Impfdatum
- 24.10.2022
- Beginn
- 05.01.2023
- Tage bis Beginn
- 73,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Cardiac monitoring abnormal
Electrocardiogram
Electrocardiogram abnormal
Fatigue
Feeling abnormal
Heart rate increased
Tachycardia
Troponin
Symptomtext
Started feeling really tired and off one day. Started tracking heart rate the next day, because heartrate was getting faster. Home heart monitor showed I was in Tachycardia. Took a low dose of husbands beta blocker and went to an urgent care the next day. Urgent care gave an EKG, heartrate was slightly elevated. Sent to ER because they wanted to test for Troponin tested for past heart attack. ER did a blood panel and another ECG. Blood pressure was 136 and pulse was 54. After blood pressure leveled out to normal, went home and rested. Went to primary care physician for a follow up. Am being sent to a Cardiologist in a couple of days and they want me to wear a Holter monitor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tachycardia
- Hospital-Tage
- -
- Labordaten
- EKG, slightly elevated
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Osteoarthritis; Inverse Psoriasis.
- Andere Medikamente
- Multimineral; vitamin D; omega 3; probiotic.
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 24.01.2023
- Impfdatum
- 08.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 20,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood glucose normal
Computerised tomogram normal
Full blood count normal
Hypoaesthesia
Magnetic resonance imaging normal
Paraesthesia
Symptomtext
On 10/28/2022 1 week after my 4th dose I started feeling facial numbness, tingling and numbing in my left arm down to my left leg. I went to the ER where I was checked for Diabetes and that was normal. I also had an MRI and CT scan which were both normal as well. I still have tingling and numbness sporadically.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- 10/28/2022 Glucose normal, 10/28/2022 MRI normal, 10/28/2022 CT scan normal, 10/28/2022 CBC normal
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- TYLENOL OTC; CENTRUM
- Allergien
- Latex
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 82,0
- Geschlecht
- M
- Eingang
- 11.01.2023
- Impfdatum
- 20.10.2022
- Beginn
- 05.01.2023
- Tage bis Beginn
- 77,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Cough
Decreased appetite
Dyspnoea
Fatigue
Myalgia
Oropharyngeal pain
Respiratory tract congestion
Symptomtext
"Patient is a 82 y.o. male with past medical history significant for hypertension, hyperlipidemia, renal transplant at a health care facility in 1978, squamous cell carcinoma, basal cell carcinoma and type 2 diabetes who presented to the ED from a local clinic w/ a cc of cough and sob. Symptoms started about five days piror to presentation. Symptoms have included cough, sore throat, weakness, sob, decreased appetite, increased fatigue, congestion, myalgias, chills. Denies n/v, diarrhea, urinary symptoms, fevers, rash, cp. Tx tried at home tylenol w/o much success. Has been vaccinated for covid with a total of 5 vaccinations as well has had his flu shot. "
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 16.12.2022
- Impfdatum
- 26.10.2022
- Beginn
- 20.11.2022
- Tage bis Beginn
- 25,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal discomfort
COVID-19
Cardiac operation
Cough
Decreased appetite
Dysphonia
Dyspnoea
Fatigue
Influenza virus test negative
Nasal congestion
Respiratory symptom
Respiratory syncytial virus test negative
Respiratory tract congestion
Rhinorrhoea
SARS-CoV-2 test positive
Weight decreased
Symptomtext
On November 7th, 2022 I was hospitalized for two days recovering from Cardiac procedures. While home convalescing I developed respiratory symptoms in the evening hours on November 20th, 2022. On November 22nd, I was swabbed and received positive COVID-19 and negative for Flu and RSV. I had hoarseness of voice, runny nose, congestion, which increased greatly and continues to plague me. The runny nose resolved a day or so ago. I still have a cough and nasal congestion, which varies in severity and sometimes effects my breathing due to the congestion. I continued to have abdominal discomfort, loss of appetite, weight loss, and fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- RSV test (11/22/22); Influenza test (11/22/22); COVID-19 rapid test (11/22/22)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension; AFIB; Spinal stenosis; Degenerating Disc; Melanoma (removed)
- Andere Medikamente
- Metoprolol; Amlodipine Besylate; Lisinopril; Eliquis; Omeprazole; Gemfibrozil; Benadryl; Natrol Melatonin;
- Allergien
- Dust Mites; Keflex
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- -
- Geschlecht
- M
- Eingang
- 16.12.2022
- Impfdatum
- 14.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Lymphadenopathy
Nipple pain
Paraesthesia
Scratch
Symptomtext
pain in the right nipple/ pain in the nipple feels like a first degree burn; he felt scratchy on knee caps; Tingly legs; swelling (Lymph node) to the right of the nipple; This spontaneous case was reported by a consumer and describes the occurrence of NIPPLE PAIN (pain in the right nipple/ pain in the nipple feels like a first degree burn), SCRATCH (he felt scratchy on knee caps), PARAESTHESIA (Tingly legs) and LYMPHADENOPATHY (swelling (Lymph node) to the right of the nipple) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Concurrent medical conditions included Diabetic. On 14-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In November 2022, the patient experienced NIPPLE PAIN (pain in the right nipple/ pain in the nipple feels like a first degree burn), SCRATCH (he felt scratchy on knee caps), PARAESTHESIA (Tingly legs) and LYMPHADENOPATHY (swelling (Lymph node) to the right of the nipple). The patient was treated with CORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, NIPPLE PAIN (pain in the right nipple/ pain in the nipple feels like a first degree burn) and LYMPHADENOPATHY (swelling (Lymph node) to the right of the nipple) had not resolved and SCRATCH (he felt scratchy on knee caps) and PARAESTHESIA (Tingly legs) had resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Patient stated that this was patient's 4th shot. Patient did not have his vaccination card handy. About a week after the bivalent booster, felt scratchy on knee caps and tingly legs. Patient used Topical Cortisone, and it went away in a couple of days. But what was still bothering him was pain in the right nipple and swelling (Lymph node) to the right of the nipple. The pain in the nipple feels like a first-degree burn. He had seen a doctor and he was going for a sonogram. This case was linked to MOD-2022-686252 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Diabetic
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 12.12.2022
- Impfdatum
- 04.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 14,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cardiac flutter
Electrocardiogram normal
Headache
Palpitations
Symptomtext
On 11/18/2022 at 10:00 AM I had a flutter in the middle of my chest. It lasted 24 hours that day, and then I called my doctor. I had a tele-visit on the phone 11/30/2022, she cad me come in for an EKG. She decided to send me to a Cardiologist. I saw the Cardiologist on 12/09/2022, I will have a patch to monitor my heart and have a stress test later. On 11/21/2022 the fluttering happened for 6 hours. On 12/01/2022 the heart fluttering happened for about two hours that day. It happened on 12/05/2022, it was mild and lasted a few minutes to half an hour with a headache for 4 days in a row then it stopped, once again on 12/07/2022 the palpitations happened again, I didn't write down how long.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- 01DEC2022 EKG normal; 09DEC2022 EKG normal
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Emphysema
- Andere Medikamente
- Famotidine
- Allergien
- Cephalexin
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 16.11.2022
- Beginn
- 16.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Bronchospasm
Condition aggravated
Dizziness
Headache
Mast cell activation syndrome
Pruritus
Respiratory disorder
Throat irritation
Throat tightness
Symptomtext
Within 5 minutes of vaccine I experienced dizziness and started to get a headache. I have chronic conditions so I didn't think too much of it. I got home and about an hour later I proceeded to have throat tightness, throat/face/inner ear itching, severe abdominal cramping, and headache. I got the vaccine 16 days ago and have continued to have issues with allergy symptoms, but now issues with bronchospasms and airway issues. This has worsened my mast cell activation syndrome symptoms significantly
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Mast cell activation syndrome, postural orthostatic tachycardia syndrome, benign joint hypermobility syndrome, fibromyalgia, small fiber neuropathy
- Andere Medikamente
- cetirizine, famotidine, corlanor, vitamin d, prazosin, lamotrigine, Benadryl, hydroxyzine, emgality every 28 days, xolair every 21 days, cromolyn sodium oral solution
- Allergien
- NSAID's, low dose naltrexone, avocado, egg, latex, adhesive, montelukast
- Vorherige Impfungen
- With the first Moderna vaccine, I had anaphylaxis 24 hours later and then days after that I had what felt like bad heartburn. Ev
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 15.11.2022
- Impfdatum
- 11.11.2022
- Beginn
- 11.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Asthenia
Condition aggravated
Neurological symptom
Symptomtext
Per report patient states he was having symptoms at 8am on 11/11/22 (right arm and leg weakness). Went to PCP that morning at 10 am and was discharged. Not knowing that he had a stroke he went to our vaccine clinic at 11 am and received the Moderna Bivalent booster and flu vaccine. Weakness and symptoms increased that day and night and he went into ER the next morning (11/12/22) where he was diagnosed with ischemic stroke, too late to administer fibrolytics. He was admitted and discharged in stable condition to follow up with neurology. Due to timeline unlikely to be precipitated by vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- Pt was feeling unwell (weakness on right arm and leg at 8 am before the injection at 11 am)
- Vorgeschichte
- Hep C, Hypertension, BPH
- Andere Medikamente
- Amlodipine 10 mg, Hydralyzine 25 mg, HCTZ 25 mg, Losartan 100 mg, Metoprolol tartrate 100 mg, Flomax 0.4 mg
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 10.11.2022
- Impfdatum
- 26.10.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 7,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
COVID-19 pneumonia
Confusional state
Cough
Fatigue
Headache
Myalgia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
On that Wednesday afternoon I developed cough and runny nose. I took Mucinex and Phenylephrine. On Thursday I felt all the symptoms. I had super fatigue, coughing, runny nose, muscle aches and headache. I had no fever. I took an at home COVID-19 test on Thursday. I continued the medication and called to arrange a PCR test on Friday the 4th and it was also positive. The doctors prescribed Paxlovid which I completed yesterday. They are improving. I still have a mild cough and mild confusion. I am having slow and continuous improvement. Prior COVID infection resulted in pneumonia so that was the rational for using Paxlovid. I have recovered around 98% good. I still have infrequent cough and confusion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- COVID-19 Home Test-11/03/2022-Positive COVID-19 PCR-11/04/2022-Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Chronic Pain Syndrome in left hip; Gender Dysphoria Treatment
- Andere Medikamente
- Synthroid; Estradiol; Spiro No lactone; Omeprazole; Voltaren; Acetaminophen 8 hour
- Allergien
- Bactrim; Pentothal
- Vorherige Impfungen
- Breakthrough case of Flu in 2017
- Staat
- NC
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Atrial fibrillation
Cardiac monitoring
Chills
Electrocardiogram abnormal
Palpitations
Pyrexia
Symptomtext
I had the vaccine around 1:30PM around 2:30PM I started to have my heart pounding and I have a smart watch and I did an EKG with that. I called my doctor, and he said yes, I am in a-fib, and I went to the emergency room locally. When I got there it had resolved itself. They put me on a monitor. Yesterday I had chills, fever like I did with the other vaccines. Today I am fine. I am going to wear the heart monitor for 14 days and see a cardiologist.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- EKG
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Gabapentin
- Allergien
- N/A
- Vorherige Impfungen
- All of the Moderna vaccines, high fever, chills, flu like symptoms.
- Staat
- MA
- Alter
- 89,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 23.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Musculoskeletal chest pain
Symptomtext
Moderna Bivalent 051D22A on October 21, 2022 at 4:30 p.m. in left arm. Patient experienced a lot of pain on right side by rib cage. Never had that pain before. She took one Extra-StrengthTylenol afternoon of Oct. 24; took two Extra-StrengthTylenol morning of Oct. 25.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Musculoskeletal chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- arthritis; walk with a rollator walker
- Andere Medikamente
- 500 mg of B-12 (1 a day); One a Day vitamins 50 Plus (one a day); 1000 mcg biotin (1 a day); 1000 IU Vitamin D (1 a day); 325 mg ferrous sulfite (1 every Monday, Wednesday, Friday).
- Allergien
- allergy to penicillin
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 21.10.2022
- Impfdatum
- 20.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Lip swelling
Pyrexia
Tremor
Vomiting
Symptomtext
vomiting, lip swelling, fever, and shaking
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 18.10.2022
- Impfdatum
- 17.10.2022
- Beginn
- 17.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Discomfort
Feeling cold
Gait inability
Hallucination
Head discomfort
Headache
Mobility decreased
Pyrexia
Sleep disorder
Symptomtext
She got her vaccine, she was fine until she went to bed. Then she got chills and was so cold and had to wear her robe and 4 blankets to try and get comfortable. She was hallucinating, felt like there were bars/clamps and around her head and pulling her hair out of her head. She was having a high fever and did not want to check so that she would not panic. She lives alone and could not get out of bed and walk due to the hallucinations. Around 3:00 AM she got up and opened her door in case her son had to take her to the hospital. She also has a headache. The hallucinations lasted for about 3 hours. She tried to sleep and would wake up with black things were inside her hood and grabbing clumps of hair and pulling her hair out, which she feels may be part of her headache. She has not gotten any AE from her previous vaccines. She is doing fine this morning, hopes it does not come back. She is not having any fever this morning. She did not take anything for her fever as she was in no state of mind or able to get up to take anything for that. She was laying down and the things in her head, and then she felt like there was a heavy metal 4 x 8 that was pushing down on her entire body to push her into a pancake. Felt like something was squeezing her and felt like she was going to die as the pressure was so heavy. She tried not to panic. The feeling was from her head to her feet, this did not last all night but it was there. She has never had hallucinations in the past. She has only had minor fever in the past. She does not want to get another vaccine. She did have COVID twice in the past, but she only had slight fever and slight chills, but was OK.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Stent placement in heart 5 years ago.
- Andere Medikamente
- Vitamin D, Metoprolol, Lipitor.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- M
- Eingang
- 04.10.2023
- Impfdatum
- 28.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site pain
Symptomtext
Soreness in his left injection site arm; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (Soreness in his left injection site arm) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness in his left injection site arm). At the time of the report, VACCINATION SITE PAIN (Soreness in his left injection site arm) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. No treatment drug was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-743491 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-743491:2023-2024 dose
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 21.06.2023
- Impfdatum
- 27.10.2022
- Beginn
- 11.02.2023
- Tage bis Beginn
- 107,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Nasal congestion
Oropharyngeal pain
Pain in extremity
SARS-CoV-2 test positive
Symptomtext
I had mild arm pain after receiving the vaccine. I tested positive for COVID-19 on 02/11/2023. I had a stuffy nose and a mild sore throat. I contacted a walk-in clinic and got a prescription for Paxlovid. I tolerated the medication without any complications. As of today, I feel good without any lingering symptoms of COVID-19.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- 11FEB2023 COVID-19 Test - Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Blood Pressure; High Cholesterol
- Andere Medikamente
- N/A
- Allergien
- Cipro
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 22.05.2023
- Impfdatum
- 18.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Symptomtext
Site: Pain at Injection Site-Medium
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 17.05.2023
- Impfdatum
- 07.11.2022
- Beginn
- 06.12.2022
- Tage bis Beginn
- 29,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Laboratory test abnormal
Symptomtext
I did not have an adverse reaction to the vaccine. I tested positive for pneumonia on 12/06/2022. I went to my doctor and got prescriptions for 5 days. As of today, I feel exhausted all the time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 06DEC2022 Pneumonia test positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- Olive oil
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 05.05.2023
- Impfdatum
- 03.11.2022
- Beginn
- 14.11.2022
- Tage bis Beginn
- 11,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Pain in extremity
Rash
Transient global amnesia
Symptomtext
I had a sore arm and achy after receiving the vaccine. On 11/14/2022, I developed a rash on my neck in the center and then it spread. As of today, I still have the rash on my back and legs. I have seen my doctor and my dermatologist, and it is undetermined what it is. I am using a topical cream to help with the symptoms. I also bath and wash my hair in liquid coal. I was hospitalized on 11/09/2022 for transit global amnesia. I spent the night for observation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- 1,0
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Breast Cancer; Grave's Disease; Oral Herpes
- Andere Medikamente
- Calcium; Vitamin D
- Allergien
- Raw Almonds; Avocado; Raw Pineapple; Seafood
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 02.05.2023
- Impfdatum
- 14.10.2022
- Beginn
- 21.03.2023
- Tage bis Beginn
- 158,0
- Dosis
- 5
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Fatigue
Malaise
Pain
SARS-CoV-2 test positive
Symptomtext
About 5 weeks ago, first time I tested positive for COVID-19. I came down with covid symptoms on 03/21/2023. I initially tested negative on 03/22/2023 in the morning. I had body aches, mild, and fatigue. I had no respiratory symptoms, no cough or congestion. I tested positive on 03/23/2023. My symptoms lasted for a couple of days. I isolated for my symptoms for ten days. I did contact my doctor office and she wrote a prescription for Paxlovid medication for me but I decided not to take it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 22MAR2023 COVID-19 Test- Negative; 23MAR2023 COVID-19 Test-Positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Type II Diabetes; Atrial Fibrillation; Chronic Depression
- Andere Medikamente
- Trulicity; Metformin; Jardiance; Atorvastatin; Eliquis; Metoprolol; Trazadone; Glimepiride; Lorazepam; Multivitamin; Vitamin D3; Magnesium
- Allergien
- None
- Vorherige Impfungen
- Flu vaccine; I experienced mild fatigue, muscle aches. Shingles vaccine- maybe second dose I had body aches.
- Staat
- MO
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 28.04.2023
- Impfdatum
- 21.10.2022
- Beginn
- 26.04.2023
- Tage bis Beginn
- 187,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Chills
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
He had chills, congestion, since I had tested positive for COVID-19 we tested him with a home COVID-19 test. The first test came back negative, we tested him again on the nest day because he was extremely congested. I called his doctor who asked that we go to the hospital to have a PCR Rapid COIVD-19 test done, this test came back positive. He was prescribed the antiviral Lagevrio that he started taking today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- 26APR2023 Home COVID-19 test - negative; 27APR2023 Home COVID-19 test - positive; 27APR2023 PCR Rapid COVID-19 test - positive
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Diabetes; Ulcerative Colitis
- Andere Medikamente
- Omeprazole; Vitamin D3; Entyvio
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 22.10.2022
- Beginn
- 25.02.2023
- Tage bis Beginn
- 126,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cough
Fatigue
Oropharyngeal pain
Pyrexia
Symptomtext
No other vaccine received the day of my booster Dry almost constant cough w fatigue and low-grade fever & sore throat
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- At home Covid test x 2
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Sleep apnea Cough variant asthma
- Andere Medikamente
- Synthroid, Wellbutrin, VitC, VitD3, Zinc, B12, MVI, Famotidine
- Allergien
- PCN,NSAIDS,ASA
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 24.04.2023
- Impfdatum
- 23.10.2022
- Beginn
- 27.03.2023
- Tage bis Beginn
- 155,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Cough
Ear pain
Influenza A virus test negative
Influenza B virus test
Influenza virus test negative
Pain
Pyrexia
Respiratory syncytial virus test negative
SARS-CoV-2 test negative
Wheezing
Symptomtext
I had a low-grade fever, coughing, wheezing, tightness in my chest, body aches, earaches. I went to Urgent Care where they ran a RSV, PCR Rapid COVID-19, Influenza A and B tests that all came back negative. I was sent home and advised to use my inhaler. On March 31, I talked to an on-call physician from my practice and was given Doxycycline and Nabumetone. On April 3, I finally got to a telehealth visit with my primary care physician and was prescribed prednisone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ear pain
- Hospital-Tage
- -
- Labordaten
- 28MAR2023 RSV test - negative; 28MAR2023 PCR Rapid COVID-19 test - negative; 28MAR2023 Influenza A and B test - negative;
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Asthma; Diabetes Type 2
- Andere Medikamente
- Effexor ER; Lamictal; Klonipin; Folic Acid; Metformin; Crestor; Riboflavin; Magnesium; Prevision; Ajovay
- Allergien
- Penicillin; Strawberries; Pineapples; Insect Venom; Pollen
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 10.04.2023
- Impfdatum
- 27.01.2023
- Beginn
- 04.04.2023
- Tage bis Beginn
- 67,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Chest X-ray normal
Fatigue
Nasal congestion
Nasopharyngitis
Pain
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
I felt like I was getting a cold, I had nasal and chest congestion, fatigue and body aches. On 04/04/2023 I took a home COVID-19 test and was positive. I reached out to the Hospital, and they prescribed Paxlovid for 5 days. I am feeling much better but still have lingering fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 04APR2023 COVID-19 home test - positive 04APR2023 Chest x-ray - normal
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma, Knee replacement surgery on 09/01/2023
- Andere Medikamente
- Wixela Inhub; Baby Aspirin; Omeprazole; Naproxen; Fluconazole; Montelukast Sodium.; Atorvastatin Calcium
- Allergien
- Sulfa drugs, Cats, Horses, Mold
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 07.04.2023
- Impfdatum
- 08.12.2022
- Beginn
- 18.03.2023
- Tage bis Beginn
- 100,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Fatigue
Headache
Illness
Malaise
Oropharyngeal pain
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
03/18 felt like I had been hit by a truck. Symptoms included cough, congestion, headache, sore throat, and fatigue. I have several illnesses and PCP instructed me to follow the plans we already had.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID-19 positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Gastroparesis; torsion dystonia
- Andere Medikamente
- SYNTHROID; bupropion; vitamin D3; LIPITOR; methylene; BENADRYL; vitamin E
- Allergien
- Allergic to everything but rocks; water; dirt.
- Vorherige Impfungen
- 2nd COVID-19 shot caused my arm to turn colors and extreme pain.
- Staat
- AZ
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 05.04.2023
- Impfdatum
- 09.12.2022
- Beginn
- 10.02.2023
- Tage bis Beginn
- 63,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Brain fog
COVID-19
Cough
Fatigue
Headache
Malaise
Pain
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Sneezing
Symptomtext
Got COVID around 2/10/23 cough, headache, fatigue, body aches. Too Paxlovid tight away with zinc, vita c and a cough suppressant, advil. Much improved in 1 week, then spiked a fever again on 2/19/23 with snot everywhere, sneezing, headache, horrible body aches an severe fatigue. I was really sick all week. Returned to work on 2t27/23 and struggled with exhaustion and brain fog.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Just 3 positive covid tests
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Depression GERDS
- Andere Medikamente
- Protonix 40 MG Prozac 40 MG Wellbutrin 150 MG Magnesium Turmeric Vita D
- Allergien
- Morphine Demoral
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 04.04.2023
- Impfdatum
- 20.10.2022
- Beginn
- 14.02.2023
- Tage bis Beginn
- 117,0
- Dosis
- 4
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Chills
Cough
Diarrhoea
Headache
Nausea
Pyrexia
SARS-CoV-2 test positive
Throat irritation
Symptomtext
I contracted COVID-19. I experienced chills, nausea, diarrhea, coughing, headache, and my throat tickled. I felt like I had a fever. I went to an urgent care. They prescribed me with some medication. I also spoke to my oncologist. My symptoms lasted for 3 to 4 days. The coughing and the throat tickle lasted for possibly 30 days, but that eventually faded away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- 14Feb2023 COVID-19 test positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Melanoma cancer
- Andere Medikamente
- Daily vitamin; topiramate; zolmitriptan; vitamin B3
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 17.03.2023
- Impfdatum
- 09.12.2022
- Beginn
- 27.02.2023
- Tage bis Beginn
- 80,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Fatigue
Headache
Nasal congestion
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
Tested positive for COVID-19 on 2/27/2023 I had fever, fatigue, headache, runny nose and congestion Prescribed a course of antiviral medication for 5 days. Tested positive for 17 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 02/27/2023 COVID-19 - positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- ASthma, Raynaud's syndrome, Reflux, Seasonal Allergies
- Andere Medikamente
- Advair; Restasis Eye drops; Tetrazene; Calcium; Lutizacal; Omega 3; Singulair;Spiriva; Pantoprazole; Linzest; Azelastine
- Allergien
- Seasonal Allergies; Foximtim
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 03.03.2023
- Impfdatum
- 09.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood test normal
Dyspepsia
Fatigue
Gastric disorder
Gastritis
Influenza
Influenza like illness
Myalgia
Nausea
Oesophageal pain
Oesophageal spasm
Pain
Pyrexia
SARS-CoV-2 test negative
Stool analysis normal
Ultrasound biliary tract normal
Symptomtext
I technically had 1 week of flu immediately. I was having fever and other flu like symptoms. My fever was not higher than 38.3 Celsius. I had body aches and was very tired, but it was nothing major. Then I got well but contracted flu again after the 30th. I tested and was negative for COVID-19. I was tired with fever and body aches. These symptoms lasted about 5 or 6 days. I experienced muscular pain. The issue with my stomach started again in December. I had difficulty with digestion, nausea, and feeling like burning in the stomach with lots of air. The worsened in the beginning of January 2023. I began having contraction like feelings in the esophagus area. I also had pain and burning in the esophagus. I called the doctor. The doctor told me these were due to heartburn and inflammation of the stomach. The provider completed a blood panel in the middle of January. I also completed a stool test at the January and both tests were normal. I was given an ultrasound as well and they said everything was fine. The doctor prescribed Famotidine 40 mg. The symptoms improved in the beginning but then got worse again. He changed the prescription to Pantoprazole Delayed Release. I am still taking them. I started taking them February 2, 2023. The symptoms did not go away 100%. I still have them every once in a while. Its still ongoing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Blood Panel-January 2023-Normal Stool Test-January 2023-Normal-No Bacteria Ultrasound-Gall Bladder-January 2023
- Aktuelle Erkrankungen
- Bronchitis -October
- Vorgeschichte
- Asthma
- Andere Medikamente
- Breo Inhaler; Montelukast; Asmanex Twisthaler; Claritin
- Allergien
- Pollen; Dust; Cat Fur
- Vorherige Impfungen
- Dose 1-COVID 19 Vaccine-Issues with stomach. 45 years old.
- Staat
- PA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 03.02.2023
- Impfdatum
- 03.11.2022
- Beginn
- 21.12.2022
- Tage bis Beginn
- 48,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Headache
Oropharyngeal pain
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
On 12/21/2022, approximately 04:00AM, I had a runny nose. I got up about 08:00AM, and I had a sore throat. I did a home COVID-19 test and it was positive. I called the doctor's office about 09:00AM and they had a nurse practitioner call me back. I was starting to get a headache and she suggested PAXLOVID. I had my first dose by noon the next day. By 12/23/2022, I was in pretty good shape. I did get a rebound case around 12/28/2022. I called the doctor's office back and the nurse practitioner this time said nothing I could do. By 12/31/2022, I was coughing really hard. Things started to improve at the first of January. I tested negative on 01/07/2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- 21DEC2022 COVID-19 test positive, 07JAN2023 COVID-19 test negative
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Generic CLARITIN; vitamin D
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 01.02.2023
- Impfdatum
- 27.10.2022
- Beginn
- 08.01.2023
- Tage bis Beginn
- 73,0
- Dosis
- 4
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Fatigue
SARS-CoV-2 test positive
Throat irritation
Symptomtext
Started feeling a scratchy throat, and feeling tired; Took a home COVID-19 test and it was positive; Had a Telehealth appointment next day and was prescribed PAXLOVID; Tested negative 2 weeks later.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- Home COVID-19 test positive; Home COVID-19 test negative.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Minocycline; QELBREE; EMERGENC; Fish oil; probiotic; elderberry gummies; garlic; magnesium; milk thistle; ashwagandha; niacin; coQ10; vitamin D3.
- Allergien
- Seasonal allergies
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 30.01.2023
- Impfdatum
- 27.10.2022
- Beginn
- 16.01.2023
- Tage bis Beginn
- 81,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Pyrexia
Rhinorrhoea
Throat irritation
Symptomtext
Mild to low fever of 100.2, runny nose scratchy throat, some fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Elderberry gummy: PAXLOVID
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 26.01.2023
- Impfdatum
- 26.10.2022
- Beginn
- 17.12.2022
- Tage bis Beginn
- 52,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Fatigue
Gait disturbance
Hyperaesthesia teeth
Nausea
SARS-CoV-2 test positive
Symptomtext
I was very fatigue, nausea, the day I went to the doctor I was very tired, I couldn't walk, they did a COVID-19 test on 12/20/2022 and it was positive. They prescribed PAXLOVID, when I took it, my mouth tested like metal, I called the doctor and he said stop taking, I felt a little bit better after that, I stayed away from everybody. Now I have problems with my teeth, I never had problems before and now they are very sensitive. I have an appointment with the dentist on the Feb 10, 2023. and then my doctor on Feb 13, 2023. I had another home test COVID-19 test on 12/30/2022 and it was negative.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 20DEC2022 COVID-19 test positive; 30DEC2022 COVID-19 test negative
- Aktuelle Erkrankungen
- Bronchitis
- Vorgeschichte
- Seizure Disorder; High Blood Pressure; Hypertension; High Cholesterol
- Andere Medikamente
- DILANTIN; atenolol; folic acid; vitamin D3; atorvastatin; calcium chloride; baby aspirin; calcium; hydrochlorothiazide
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 23.01.2023
- Impfdatum
- 21.10.2022
- Beginn
- 05.01.2023
- Tage bis Beginn
- 76,0
- Dosis
- 5
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood pressure increased
Blood test
COVID-19
Chest X-ray
Electrocardiogram
Fatigue
Headache
Malaise
Oropharyngeal pain
Rhinorrhoea
SARS-CoV-2 test positive
Sneezing
Symptomtext
I received the Moderna Bivalent COVID-19 booster on 10/21/2022. On 1/5/2023, I woke up not feeling well. I had a dull headache and a sore throat. As the day progressed, they grew more intense, but I didn't develop any other symptoms. I took my BP and my temperature, both of which were within the normal range. I also had a little bit of malaise and fatigue. I took a home antigen test that day and got a positive result. I had a video chat with a PA at the clinic I go to, and I was prescribed PAXLOVID, which I began taking that evening. I was also instructed to stop taking my rosuvastatin while I was on PAXLOVID on account of a negative interaction between the two. On 1/6/2023, I continued to have a sore throat, headache, and a little bit of tiredness. On 1/7/2023. my headache was fading, though I still had a sore throat. My BP also shot up, and I had to go to the ER. At the ER, when they took my BP, it registered at 204/98. They conducted blood work, a chest X-ray, and an EKG. After I was at the ER for a couple of hours, my BP had decreased to about 157/85. They didn't give me any treatment or medication, and they advised me to see my PCP. I saw my PCP on 1/12/2023. When I was at the PCP's office, my BP was tolerable, but it was still a bit higher than ideal. My PCP referred me to a cardiologist, whom I am scheduled to see at the end of this month. After I began taking the PAXLOVID, my symptoms steadily began to fade, and by the time I saw my PCP on 1/12/2023, my symptoms were pretty much gone. I took a home antigen test on 1/17/2023 and got a negative result. Even though I had a negative result, though, I had a runny nose and sneezing, which lasted from 1/17/2023 until 1/21/2023. I don't know if I had a cold or RSV at that point. I took CORICIDIN HBP to treat it, and it was effective.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- 1/5/2023 home antigen test positive result; 1/17/2023 home antigen test negative result; 1/7/2023 ER blood pressure check 204/98.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Hypertension; High Cholesterol.
- Andere Medikamente
- Lisinopril; rosuvastatin; calcium with vitamin D3.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 23.01.2023
- Impfdatum
- 21.10.2022
- Beginn
- 14.12.2022
- Tage bis Beginn
- 54,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Fatigue
Headache
Heart rate abnormal
Nasal congestion
Nausea
Oropharyngeal pain
Pyrexia
SARS-CoV-2 test positive
Sinus congestion
Symptomtext
I had a headache on Wednesday and Thursday. My throat was also hurting. On Friday I had a fever thru the night and still tested negative. I also had some sinus congestion and nausea. On Saturday I had fever, nasal congestion, and nausea. My fever got 103.0. I finally tested positive on Saturday. I went to a walk in center and had a COVID 19 test completed and it was also positive. My symptoms got worse over the weekend. I was very congested and could not breath out of my nose. My doctor prescribed Sudafed and Paxlovid but I did not take the Paxlovid as I was past the date. I rotated Motrin and Tylenol as well. I still have lingering fatigue but everything else got better after 2 weeks. I do not feel like I have recovered. My heart rate still jumps around like it did when I had post COVID-19 in 2020.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- COVID 19 Home Test-December 17, 2022-Positive COVID 19 Test-December 17, 2022-Positive
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Does not wish to provide
- Andere Medikamente
- Lupron Chemotherapy Injection; Vitamin D; Calcium; Zinc; Vitamin B12; NAC
- Allergien
- Bactrim; Imitrex; Naproxen; Clindamycin; Amoxicillin
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 20.01.2023
- Impfdatum
- 16.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 5
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Blood alkaline phosphatase increased
Bone scan abnormal
Ligament disorder
Ligamentitis
Orthosis user
Pain
X-ray normal
Symptomtext
My rib bones, the ligaments were inflamed, and it was painful when I bent forward. I had an X-Ray. But the X-Ray was done too late, and the inflammation had healed. I had a bone scan first and that doctor requested and X-Ray. The ligaments in my knees are acting up and it felt like my knees came apart. It was really, painful. I had to wear my knee brace. My alkaline phosphates are too high, and I do not have an explanation for this yet. I have had not treatment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Bone skin, abnormal, unknown; X-Ray, normal, unknown.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- High Cholesterol; Prediabetic
- Andere Medikamente
- Rosuvastatin; vitamin D3; cinnamon; turmeric; coQ10
- Allergien
- Nickel
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 21.12.2022
- Impfdatum
- 19.12.2022
- Beginn
- 19.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Chills
Cough
Decreased appetite
Lymph node pain
Lymphadenopathy
Nasal congestion
Pyrexia
Rhinorrhoea
SARS-CoV-2 test positive
Symptomtext
I received my bivalent vaccine and just hours later, the lymph nodes in my neck began swelling and were painful to touch. I had body chills and aches with a high-grade fever of 101.7F. I had a cough and nasal congestion with a lot of drainage. I have completely lost my appetite. I've been taking DayQuil and Nyquil for my symptoms. I took two at-home COVID-19 tests on 12/20/2022 and both came back positive. I called my physician who prescribed me Paxlovid, but I haven't gone to pick to up the prescription. As of now, I'm feeling better than I was the day before, but my lymph nodes are still swollen and my nasal congestion/drainage is still bothering me.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- COVID-19 Test: 12/20/2022
- Aktuelle Erkrankungen
- Common Cold
- Vorgeschichte
- High Blood Pressure; High Cholesterol; Non-Fatty Liver Disease
- Andere Medikamente
- Atorvastatin; Losartan; Aspirin; Zinc; Vitamin D3; Magnesium; Vitamin C
- Allergien
- Pravastatin; Lisinopril; Metoprolol
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 15.12.2022
- Impfdatum
- 09.12.2022
- Beginn
- 09.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site pain
Wrong product administered
Symptomtext
arm soreness 12 hours after vaccination; inadvertently administered with Moderna COVID-19 Vaccine Bivalent instead of the 1st dose of the primary series; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (arm soreness 12 hours after vaccination) and WRONG PRODUCT ADMINISTERED (inadvertently administered with Moderna COVID-19 Vaccine Bivalent instead of the 1st dose of the primary series) in a 20-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Patient's relevant medical history/conditions, allergy, concomitant medications and risk factor was unknown. On 09-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 5 milliliter. On 09-Dec-2022, the patient experienced VACCINATION SITE PAIN (arm soreness 12 hours after vaccination) and WRONG PRODUCT ADMINISTERED (inadvertently administered with Moderna COVID-19 Vaccine Bivalent instead of the 1st dose of the primary series). At the time of the report, VACCINATION SITE PAIN (arm soreness 12 hours after vaccination) and WRONG PRODUCT ADMINISTERED (inadvertently administered with Moderna COVID-19 Vaccine Bivalent instead of the 1st dose of the primary series) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: Patient's relevant medical history/conditions, allergy, concomitant medications and risk factor was unknown.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 26.11.2022
- Impfdatum
- 20.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Malaise
Pyrexia
SARS-CoV-2 test
Vaccination site pain
Symptomtext
generalized malaise; Headache; injection site soreness; fever beginning 13h post-injection; This spontaneous case was reported by a pharmacist and describes the occurrence of MALAISE (generalized malaise), HEADACHE (Headache), VACCINATION SITE PAIN (injection site soreness) and PYREXIA (fever beginning 13h post-injection) in a 41-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Co-suspect product included non-company product INFLUENZA VACCINE INACT SPLIT 4V (QUADRIVALENT INFLUENZA VACCINE) for an unknown indication. The patient's past medical history included Viral infection (influenza like viral infection) in October 2022. Previously administered products included for Product used for unknown indication: Pfizer in January 2021 and pfizer in February 2021. Past adverse reactions to the above products included No adverse event with Pfizer and pfizer. On 20-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE INACT SPLIT 4V (QUADRIVALENT INFLUENZA VACCINE) (unknown route) 1 dosage form. In November 2022, the patient experienced MALAISE (generalized malaise), HEADACHE (Headache), VACCINATION SITE PAIN (injection site soreness) and PYREXIA (fever beginning 13h post-injection). At the time of the report, MALAISE (generalized malaise), HEADACHE (Headache), VACCINATION SITE PAIN (injection site soreness) and PYREXIA (fever beginning 13h post-injection) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative) Home COVID test. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. No known history of Covid-19 Infection. No treatment information was provided by the reporter. This case was linked to MOD-2022-675780 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Home COVID test
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Viral infection (influenza like viral infection)
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 80,0
- Geschlecht
- F
- Eingang
- 25.11.2022
- Impfdatum
- 22.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Rash erythematous
Vaccination site rash
Symptomtext
It was bright red; severe rash that started in the warm areas and then it spread all over, It was only from the groin to the top of breast in the front of body on the left and right side, fiery rash, it was sore; some rash on arm where had the injection; This spontaneous case was reported by a patient and describes the occurrence of RASH ERYTHEMATOUS (It was bright red), RASH (severe rash that started in the warm areas and then it spread all over, It was only from the groin to the top of breast in the front of body on the left and right side, fiery rash, it was sore) and VACCINATION SITE RASH (some rash on arm where had the injection) in an 80-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. It was reported that patient had no medical history. Patient never had COVID positive test or diagnosis. Previously administered products included for Product used for unknown indication: FLU [INFLUENZA VACCINE] (flu shot one week before 22Oct2022 (patient thoughts it was around 15Oct2022)) on 15-Oct-2022. Past adverse reactions to the above products included No adverse event with FLU [INFLUENZA VACCINE]. Concurrent medical conditions included Allergy to arthropod bite (Allergy to fire ants, had an anaphylactic shock with fire ants). On 22-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (It was bright red), RASH (severe rash that started in the warm areas and then it spread all over, It was only from the groin to the top of breast in the front of body on the left and right side, fiery rash, it was sore) and VACCINATION SITE RASH (some rash on arm where had the injection). The patient was treated with HAMAMELIS VIRGINIANA EXTRACT (WITCH HAZEL [HAMAMELIS VIRGINIANA EXTRACT]) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (It was bright red), RASH (severe rash that started in the warm areas and then it spread all over, It was only from the groin to the top of breast in the front of body on the left and right side, fiery rash, it was sore) and VACCINATION SITE RASH (some rash on arm where had the injection) had resolved. Concomitant drugs were not reported. On 09-Jan-2021, Patient received first dose of moderna shot with lot number 012120A. On 10-Feb-2021, Patient received dose second dose of moderna shot with lot number 010M20A. On 22-Oct-2021, Patient received 1st booster of moderna shot with lot number 011F21A. It was reported that patient thought it was shingles. Patient was uncomfortable but not life-threatening. Patient had no problem with other three doses. Patient seek office visit on 26-Oct-2022. The patient reported trying everything with witch hazel, cortisone and medicated powder. Nothing worked. She went to the doctor, who gave her a big shot. It was a steroid. Two days later, she took steroid, antihistamine pills and her rash recovered. Most recent FOLLOW-UP information incorporated above includes: On 21-Nov-2022: No new information received.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy to arthropod bite (Allergy to fire ants, had an anaphylactic shock with fire ants)
- Vorgeschichte
- Comments: It was reported that patient had no medical history. Patient never had COVID positive test or diagnosis.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 14.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 08.11.2022
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Exposure to SARS-CoV-2
Fatigue
Feeling abnormal
Nasal congestion
Paranasal sinus hypersecretion
SARS-CoV-2 test positive
Sneezing
Symptomtext
Starting 11/08/2022, I tested myself for COVID-19 at home and it was positive. I only tested myself due to known exposure the Saturday prior (11/05/2022). I normally have allergy symptoms like sneezing which is the only thing I was experiencing. I called the doctor when I tested positive and I was told to treat symptoms unless it gets worse. I had the same symptoms on the 9th except slightly more sinus drainage and it felt more like a cold. I had some coughing but likely due to post nasal drip. I felt better by the 10th with breathing but not 100%. I felt slight brain fog but was still able to work. By Friday and Saturday, I was feeling much better so I tested myself again, but was still COVID-19 positive. Despite some slight fatigue and nasal congestion, I am feeling okay as of today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- At home COVID-19 test (11/08/2022): positive
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- High Cholesterol; Allergies
- Andere Medikamente
- ZYRTEC; LIPITOR; vitamin D; fish oil; vitamin B complex; aspirin; multivitamin; folic acid; zinc
- Allergien
- NSAID (can't remember name)
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 11.11.2022
- Impfdatum
- 11.11.2022
- Beginn
- 11.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Urticaria
Symptomtext
Patient erupted in hives covering extremities and thorax. Reaction occurred within 5-10 minutes. Patient reported no other symptoms associated with reaction and denied any itchiness or respiratory issues.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 11.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site swelling
Injection site vesicles
Injection site warmth
Pain in extremity
Symptomtext
Moderna COVID-19 Vaccine, Bivalent EUA COPY/PASTE of visit note with provider 11/08/22: Pt presents for evaluation of left upper arm swelling, blistering and redness, which he noticed the day after he received both his bivalent COVID booster and the flu shot in the left deltoid. He requested that the vaccines be given in the same arm so he would have one good arm as he is the caregiver for his 93-year old mom. His arm felt sore within hours of the vaccine, but he did not examine the site. The following day, the soreness was worse and he observed redness, swelling, warmth and a large blister. He took no measures to treat this. The blistering resolved and now it looks like a burn. It feels like a burn. There is no deep pain or arm weakness. He has not experienced fever.or chills.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- COPY/PASTE of visit note 11/08/22: Diagnoses and all orders for this visit: Vaccine reaction, initial encounter Comments: hypersensitivity reaction, local - use triamcinolone ointment tid and silvadene bid Orders: - triamcinolone (ARISTOCORT) 0.1 % topical ointment; Apply topically 3 (three) times daily. - silver sulfADIAZINE (SILVADENE) 1 % topical cream; Apply topically 2 (two) times daily. Blistering of skin Comments: hypersensitivity reaction, local - use triamcinolone ointment tid and silvadene bid Orders: - triamcinolone (ARISTOCORT) 0.1 % topical ointment; Apply topically 3 (three) times daily. - silver sulfADIAZINE (SILVADENE) 1 % topical cream; Apply topically 2 (two) times daily.
- Aktuelle Erkrankungen
- Dizziness X 1 month prior to vaccination. Reason for visit on 10/31/22 was dizziness
- Vorgeschichte
- Borderline HTN noted 08/2014 OA of knee noted 09/2014 BPH noted 07/2016 Panic Disorder noted 02/2018 Claustrophobia noted 10/2020
- Andere Medikamente
- Amoxicillin X 7 days prescribed 10/05/22 for dizziness- completed Prednisone X 10 days prescribed 10/11/22 for dizziness- completed Augmentin X 14 days prescribed 10/14/22 for dizziness- completed
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 4,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Feeling abnormal
Headache
Hyperhidrosis
Pain
Pyrexia
Symptomtext
Fatigue, feverish, sweaty, headache, ached all over, felt like I was out of my mind/head. Had regular flu shot with bivaliant booster. Have never had any adverse symptoms following boosters.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Rheumatoid Arthritis
- Andere Medikamente
- -
- Allergien
- Allergy to codeine.
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Rash
Symptomtext
Systemic: Allergic: Itch Generalized-Mild, Systemic: Rash on stomach.-Mild
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 06.11.2022
- Impfdatum
- 20.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Patient comes in complaining of bruising at injection site following moderna bivalent vaccine. Previously he had gotten pfizer doses for primary series. Bruising about 3 inch diameter. No improvement since day of vaccine. Not painful. Patient is not on blood thinners that he is aware of. Patient states site is not warm to touch and not particularly tender. Refered patient to PCP for followup.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 9,0
- Geschlecht
- F
- Eingang
- 04.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 04.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Headache
Pyrexia
Vomiting
Symptomtext
Fever, headache, vomiting, fatigue
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Daily Gummy Vitamins
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 04.11.2022
- Impfdatum
- 21.10.2022
- Beginn
- 22.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Malaise
Ocular hyperaemia
Pain
Pain in extremity
Rib fracture
Symptomtext
I had painful arm for 4 days, and a headache and bloodshot eyes that lasted two days. This was not as bad as the previous reactions I had to my Moderna shots, which induced full-on flareups of my Relapsing Polychondritis. Nevertheless the sore arm, bloodshot eyes, and headache seem worth reporting. I received this Moderna booster on Friday October 21, 2022 after breaking my ribs on Tuesday, October 18. I did not wish to have a severe COVID infection shortly after breaking two ribs. It is now November 4, and I did not catch any respiratory infections, so the pain and malaise after the shot appear to have been worth it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Broken Ribs 9 & 10 on right side
- Vorgeschichte
- Relapsing Polychondritis Type 1 Diabetes Common Variable Immune Deficiency
- Andere Medikamente
- Insulin, Hizentra, Tresiba, Hydroxychloroquine, Ibuprofen 800 MG, Metformin ER
- Allergien
- gluten
- Vorherige Impfungen
- Moderna on 2/23/2021 and 3/23/2021.
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 02.11.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Myalgia
Pyrexia
Vomiting
Symptomtext
vomiting x5 episodes, fever (tmax 101), headache, myalgia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- COVID/flu PCR testing ordered
- Aktuelle Erkrankungen
- Recent AOM
- Vorgeschichte
- mild persistent asthma, idiopathic urticaria, feeding problem in child
- Andere Medikamente
- -
- Allergien
- NKDA
- Vorherige Impfungen
- reports vomiting with previous COVID vaccination (Pfizer)
- Staat
- WI
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 25.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Arthralgia
Cough
Drainage
Dysphonia
Ear pain
Facial pain
Fatigue
Headache
Hypersomnia
Hypoaesthesia
Injection site pain
Injection site pruritus
Injection site swelling
Insomnia
Joint swelling
Lip blister
Lip pain
Lip swelling
Symptomtext
Vaccine on Tuesday 10/25 in afternoon. Tired that night, no other concerns. Tired on Wednesday 10/26 during day but functional with increasing congestion. By evening, raspy voice, deeper congestion, tired with sore throat developing overnight. Thursday, 10/27 woke with strong congestion, deeply raspy voice, sore throat. Symptoms through day included headache, fatigue, stuffy nose, ear aches x2, body aches, sore throat, cough (drainage). Slept off an on through day, rested. Fever at 100.9 on digital thermometer at 9:48 PM took 650 MG of aspirin. Fever at 100.2 at 10:11 PM. Slept through night, temp at 10:56AM was 98.1F on Friday, 10/28 noted fatigue, body aches, sore throat, stuffy nose. Both arms were beginning to hurt, lower arms at joints. Call Health Systems nurse call line at 12:34 PM, reviewed symptoms including hands and had stopped using OTC Anti-Itch cream at that point and began with frequent soap / water hand washing routine and Aveeno unscented hand lotion. Nurse confirmed at-home appropriate with aspiring / benedryl but to call or come in if symptoms got worse. Took Aspirin 325 mg and benedryl. 98.8 F at 12:36PM. Took picture of rash on left hand at 12:41 PM, spreading up wrist area for comparison. Rash on right hand was in early stages. Aspirin 325 mg at 2:30 PM and Benedryl x 1 at 3:30 PM. 99.9 at 5:18 PM and 100.4 at 6:16 PM.100.6 at 9:20 PM and 101.3 at 9:47 PM. Slept throughout day, fatigue with rash continuing to develop on both hands. Somewhere in here I began to notice slight swelling on face near left side of lower lip. By 10:00 PM, headache, rash (swelling still visible in hands), joints aching from swelling. Ibuprofen 200 mg and benadryl x 2 at 10:09 PM and to bed. 100.9 at 10:26 PM. Benadryl x1 at 4:30 AM. Urgent Care visit on Saturday, October 29th with Rx for Prednisone, first does at 1:30 PM. Bendaryl at 2:40 PM. Temps 99.5 at 2:45 PM, 99.5 at 6;42 PM. Slept most of day. Temp at 98.1 at 8:52 AM on Sunday, 10/30 with stuffy nose, rash, headache and fatigue. Aspriin 325 mg and Prednison at about 9:00 AM. Temp at 98.6 at 10:42 AM, sudafed and benedryl at 10:47 AM. Temp at 98.4 at 1:59 PM,. Temp at 98.2 at 9:44 PM, stuffy nose, rash (here's where I see documentation of rash on face, remember slight swelling at lower left edge of lips. Remember telling my husband I felt pretty good - tired - other than the swelling on face, rash on hands was resolving. Benedryl x2 at 10:55 PM. Sleep difficult - "crazy legs" which I assumed was from the prednisone, lip painful and put on Blistex. Lips more pain, got up shortly after midnight and swelling in lip had increased a great deal - lower lip probably double normal size, took a couple of photos of lip swelling- removed Blistex and applied cold compress to area. Little to no sleep. Temp 98.1 at 3:28 AM on Monday, 10/31. Aspirin 650 mg 3:30 AM. Sudafed 6:00 AM. Woke husband to return to urgent care, swelling of lower lip and now numbness up right cheek and into chin. Pain in right sinus, have history of recurring sinus infections. Shortly after arrival at Urg Care, noted that blisters (pockets) had formed on inside of lower lip. Pain was present in face area, exhausted. Pain scale rating, probably a 5 of 10 at most. Administered Cetirizine (ZyrTEC) and assessed after 30 minutes. I could feel some relief. Discharged to home with continuation of Prednisone (original 5 day course of treatment), Zithromax Z-Pak (new) for sinus infection, and Zyrtex 10 mg daily for 15 days. Slept the entire day and night. Severe arm pain in right hand / wrist and left shoulder / elbow developed throughout Monday night. Noted itching in elbow and underarms beginning sometime that night. Awoke Tuesday AM, pain scale assessment of pain in arms was at least an 8 of 10. Took Zyrtec about 4:30 AM. Took Prednisone sometime between 8 and 10 after making my way from bedroom to recliner, pain was overwhelming, fatigue was significant. Notable swelling in underarms, above elbows, and behind right knee. Slept upright in recliner for a few hours, when awoken, pain in arms was diminished but fatigue was awful. Showered and back to bed for the entire day and night. Awoke on Wednesday, felt pretty good and was actually functional throughout day. Final dose of prednisone taken Wednesday morning. Thursday, I am again slightly fatigued and my neck, underarms, and side of my face are starting to itch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Typical seasonal allergies - stuffy nose / congestion from same.
- Vorgeschichte
- Seasonal allergies, all year long.
- Andere Medikamente
- Multivitamin, Loratadine, Melatonin, daily - taken at bedtime. Cimetidine, as needed, may or may not have taken that night.
- Allergien
- Penicillin, sulfa, novocaine. Contact sensitivity to certain adhesives. Respiratory reaction to certain scents / strong perfumes.
- Vorherige Impfungen
- 10/2021 Moderna Booster - respiratory / fatigue x 24 to 48 hours; 05/2022 Moderna booster - respiratory, high fevers, fatigue x
- Staat
- PA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 03.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site erythema
Vaccination site pain
Vaccination site swelling
Vaccination site warmth
Symptomtext
Erythema on the left arm injection site after Bivalent Booster / Redness spread on the injected arm 1 day after Bivalent Booster; Warmth on the left arm injection site after Bivalent Booster / Hot to the touch left arm injection site after Bivalent Booster / Very blunt left arm injection site after Bivalent Booster; Swelling on the left arm injection site after Bivalent Booster; Pain on the left arm injection site after Bivalent Booster; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (Erythema on the left arm injection site after Bivalent Booster / Redness spread on the injected arm 1 day after Bivalent Booster), VACCINATION SITE WARMTH (Warmth on the left arm injection site after Bivalent Booster / Hot to the touch left arm injection site after Bivalent Booster / Very blunt left arm injection site after Bivalent Booster), VACCINATION SITE SWELLING (Swelling on the left arm injection site after Bivalent Booster) and VACCINATION SITE PAIN (Pain on the left arm injection site after Bivalent Booster) in a 59-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. No Medical History information was reported. On 28-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-Oct-2022, the patient experienced VACCINATION SITE ERYTHEMA (Erythema on the left arm injection site after Bivalent Booster / Redness spread on the injected arm 1 day after Bivalent Booster), VACCINATION SITE WARMTH (Warmth on the left arm injection site after Bivalent Booster / Hot to the touch left arm injection site after Bivalent Booster / Very blunt left arm injection site after Bivalent Booster), VACCINATION SITE SWELLING (Swelling on the left arm injection site after Bivalent Booster) and VACCINATION SITE PAIN (Pain on the left arm injection site after Bivalent Booster). At the time of the report, VACCINATION SITE ERYTHEMA (Erythema on the left arm injection site after Bivalent Booster / Redness spread on the injected arm 1 day after Bivalent Booster), VACCINATION SITE WARMTH (Warmth on the left arm injection site after Bivalent Booster / Hot to the touch left arm injection site after Bivalent Booster / Very blunt left arm injection site after Bivalent Booster), VACCINATION SITE SWELLING (Swelling on the left arm injection site after Bivalent Booster) and VACCINATION SITE PAIN (Pain on the left arm injection site after Bivalent Booster) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant information provided Patient received First Primary dose: On 27MAR2021 (Lot# 013B21A & Exp. Date: unknown). Patient received2nd Primary dose: On 24APR2021 (Lot# 045B21A & Exp. Date: unknown). Patient received First Monovalent Booster shot (3rd Shot) : On 03DEC2021 (Lot# 012H21B & Exp. Date: unknown). On 28OCT2022, in the evening, patient started having injection site reactions: Erythema, Warmth, Swelling and Pain on the injection site, on the left arm. The Redness spread on the injected arm the next day. The left arm was Hot to the touch and very blunt. She has not seen a doctor. No treatment information provided
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 37,0
- Geschlecht
- F
- Eingang
- 01.11.2022
- Impfdatum
- 21.10.2022
- Beginn
- 22.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Neck pain
Pain
Rash erythematous
Skin lesion
Symptomtext
The day following vaccine in left arm patient (37 y/o female family physician) developed raised erythematous painful lesions left neck and supraclavicular region as well as upper back. Not clearly vesicular but questionable shingles, did not seek treatment but more lesions did appear in following week.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Nexplanon in place, right arm
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 31.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pruritus
Rash
Urticaria
Symptomtext
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Severe, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Additional Details: PT SAYS HAS RASH OVER WHOLE BODY, SHE SHOWED HIVES , RASH ON HER ARM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 31.10.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Balance disorder
Dizziness
Fall
Symptomtext
Systemic: Dizziness / Lightheadness-Mild, Systemic: Loss Balance-Mild, Additional Details: Patient recieved a moderna bivalent booster at 10:30 am. After the patient was seated and waited for 15 min and about to walk out of the pharmacy, the patient felt dizzy and lost her balance. She fell backwards landing on her back.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 27.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Chills
Decreased appetite
Diarrhoea
Headache
Impaired work ability
Loss of personal independence in daily activities
Myalgia
Nausea
Pyrexia
Thirst
Vomiting
Symptomtext
During the night after the shot, chills, fever, extreme thirst, nausea, vomiting, diarrhea; within 24 hours, weakness, headache, muscle ache, nausea, continued vomiting and diarrhea, and loss of appetite,. These symptoms continued for 48 hours after the vaccine and then began to lift on day 3. Unable to work or function for a full two days. These side effects are similar to those experienced with an earlier Moderna booster. Initial (Pfizer) shots also produced strong side effects, though not as severe and lengthy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- Zyrtec allergy medicine, Estring
- Allergien
- None
- Vorherige Impfungen
- But only to Covid vaccines
- Staat
- NV
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Fall
Pneumothorax
Rib fracture
Skin swelling
Wrist fracture
Symptomtext
PUFFINESS IN RIGHT ARM, SUPPOSED DIZZINESS THE DAY AFTER AND CONTINUING UNTIL 10/23 WHEN THE PT HAD A FALL AND WAS TRANSPORTED TO HOSPITAL WHERE SHE SUSTAINED A FRACTURED WRIST, FRACTURED RIBS, AND A PUNCTURED LUNG
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- movement /tremor disorders
- Andere Medikamente
- alendronate, mesalamine, primidone, phenytoin,protonix
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 23.10.2022
- Impfdatum
- 17.10.2022
- Beginn
- 18.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Rash pruritic
Symptomtext
Per patient diarrhea started on Tuesday and stomach broke out in an itchy rash Thursday night.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- Alendronate
- Allergien
- No known drug allergies
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 23.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Induration
Pain
Pain in extremity
Pruritus
Skin warm
Swelling
Symptomtext
Erythema- painful, swollen area; hard bump; very itchy and red;
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- none; 3 days later and the arm is still sore and the redness is still very apparent. No longer warm to the touch. The area is almost perfectly round, and at it's largest had a diameter of 2"
- Aktuelle Erkrankungen
- Small intestinal bacterial overgrowth (SIBO)
- Vorgeschichte
- spondylolisthesis; osteoarthritis of lower extremities; functional diarrhea; ADHD with OCD and depressive disorder; spinal stenosis; chronic kidney disease; metabolic disorder;
- Andere Medikamente
- citalopram 10mg qd; colchichine 0.6mg qd; furosemide 40mg qd; gabapentin 200mg hs; HP Multivitamin qd; Omega 3 1000 iu qd; Ozempic 2mg q week; pantoprazole 40mg qd; potassium citrate 10mEq 2 tabs qd; pramipexazole 0.25mg bid; rosuvastin 5m
- Allergien
- Soy; nickel; procaine; marcaine; bupivicaine;
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 96,0
- Geschlecht
- F
- Eingang
- 22.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site bruising
Injection site haematoma
Injection site pain
Injection site pruritus
Symptomtext
Patient's daughter reported 3 days after vaccination that the patient has extensive bruising at the injection site indicative of a hematoma as well as itching at the site of injection. Patient reports have pain and issues with the itching around the injection site also. Advised patient's daughter to take OTC medication appropriate for her elderly age as well as to be cautious when taking Benadryl for itching (potentially harmful drug for elderly patients per List) and to monitor for side effects. Patient's daughter will monitor the situation and will report back if things do not improve within two days or a week time interval.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Vomiting
Symptomtext
severe vomiting within 24 hours of vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vomiting
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Covid
- Vorgeschichte
- -
- Andere Medikamente
- metformin, lexapro, rosuvastatin, lisinopril
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 20.11.2023
- Impfdatum
- 21.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Post-acute COVID-19 syndrome
SARS-CoV-2 antibody test
Somnolence
Symptomtext
very very sleepy; got covid in spring of 2022 after their last Moderna shot/had long covid; This spontaneous case was reported by a patient and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (got covid in spring of 2022 after their last Moderna shot/had long covid) and SOMNOLENCE (very very sleepy) in an 85-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: COVID-19 vaccine (2nd dose) on 11-Feb-2021, COVID-19 vaccine (1st dose, Lot: DU4M20A) on 04-Apr-2021 and COVID-19 VACCINE (Lot: 05E21A) on 29-Oct-2021. Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, COVID-19 vaccine and COVID-19 vaccine. Concurrent medical conditions included Blood pressure high, House dust mite allergy, Penicillin allergy, Allergy to molds, Allergy to plants (certain plants) and Allergic reaction to antibiotics (Reactions to different antibiotics). Concomitant products included CLONIDINE, METOPROLOL and AMLODIPINE for Blood pressure high. On 21-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2022, the patient experienced POST-ACUTE COVID-19 SYNDROME (got covid in spring of 2022 after their last Moderna shot/had long covid). On an unknown date, the patient experienced SOMNOLENCE (very very sleepy). At the time of the report, POST-ACUTE COVID-19 SYNDROME (got covid in spring of 2022 after their last Moderna shot/had long covid) and SOMNOLENCE (very very sleepy) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, SARS-CoV-2 antibody test: 21,000 proteins. It was reported that patient got covid in spring of 2022 after last moderna shot. She has had long covid and had a spike protein test and had 21,000 proteins. Patient could not get any tireder than they were right now. The only reaction had to the vaccine was that they were very very sleepy. when got covid it was the same problem they had. With long covid patient was physically exhausted. Treatment medication was not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Post-acute COVID-19 syndrome
- Hospital-Tage
- -
- Labordaten
- Test Date: 2022; Test Name: spike protein test; Result Unstructured Data: 21,000 proteins
- Aktuelle Erkrankungen
- Allergic reaction to antibiotics (Reactions to different antibiotics); Allergy to molds; Allergy to plants (certain plants); Blood pressure high; House dust mite allergy; Penicillin allergy
- Vorgeschichte
- -
- Andere Medikamente
- CLONIDINE; METOPROLOL; AMLODIPINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 31.08.2023
- Impfdatum
- 10.11.2022
- Beginn
- 17.12.2022
- Tage bis Beginn
- 37,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Symptomtext
Hospitalization for COVID-19
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- M
- Eingang
- 09.06.2023
- Impfdatum
- 23.05.2023
- Beginn
- 23.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. No Medical History information was reported. On 23-May-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 23-May-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine). No concomitant medication was reported. No treatment information was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-727945 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-727945:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 09.06.2023
- Impfdatum
- 26.05.2023
- Beginn
- 26.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. No Medical History information was reported. On 26-May-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 26-May-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with an expired dose of the Moderna COVID-19 bivalent vaccine). No concomitant medications were provided. It was reported that patient did not reported any adverse reactions at this time. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-727939 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-727939:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 08.06.2023
- Impfdatum
- 26.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Immunisation reaction
Symptomtext
Adverse effect of other vaccines and biological substances, initial encounter on 2022-10-28.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunisation reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Back pain NOS; Contusion of right back wall of thorax, initial encounter; Need for immunization against single bacterial diseases; Neoplasm of uncertain or unknown behaviour, unspecified; Body mass index [BMI] 26.0-26.9, adult
- Vorgeschichte
- -
- Andere Medikamente
- CYCLOSPORINE 0.05 % OP EMUL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 02.06.2023
- Impfdatum
- 26.05.2023
- Beginn
- 26.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Pt was given the covid Vaccine and no visible reaction during there 15 min . staff vaccinated the patient after they realize the vaccine was passed it use date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None at ths time
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- unknown
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 02.06.2023
- Impfdatum
- 23.05.2023
- Beginn
- 23.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Staff administer the vaccine that was expired, Pt was vaccinated with no reactions, Pt was monitored for the 15 min and had no shortness of breath no visible reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- No laboratory test have been performed as of yet
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- N/A
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 26.05.2023
- Impfdatum
- 24.05.2023
- Beginn
- 24.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Product storage error
Symptomtext
Patient recieved vaccine 4 days after expiration date. Patient was here for the allotted time of 15 minutes after and had no reactions. Was not caught that vaccine was expired till entered into epic. Provider notified and Moderna was notified that did a Moderna medical inquiry to find the viability of the vaccine after date of expiration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on May 24, 2023 from lot number 051D22A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- HYPERLIPIDEMIA Mild, anxiety, and depression
- Andere Medikamente
- acetaminophen (TYLENOL) 325 MG tablet, albuterol 108 (90 Base) MCG/ACT inhaler, alclometasone (ACLOVATE), amphetamine-dextroamphetamine (Adderall) 10 MG tablet, aspirin 81 MG chewable tablet, benzonatate (Tessalon Perles) 100 MG capsule, Ch
- Allergien
- Shellfish Allergy (food Or Med) and Penicillin's
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 84,0
- Geschlecht
- M
- Eingang
- 05.05.2023
- Impfdatum
- 03.05.2023
- Beginn
- 05.05.2023
- Tage bis Beginn
- 2,0
- Dosis
- 7+
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
The client came into our clinic for a bivalent booster, we checked his vaccine card and age, based on his age and the amount of time since the last covid vaccine (10/2022) on his card we administered a dose. When staff was later entering this vaccine into the system, it was found that he had received a bivalent vaccine in 01/2023 at another facility which was not noted on his vaccine card.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 01.05.2023
- Impfdatum
- 01.05.2023
- Beginn
- 01.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Incorrect dose administered
Symptomtext
PATIENT RECEIVED INITIAL COVID VACCINATION (PFIZER) 4/5/2023. SECOND COVID VACCINATION (BIVALENT MODERNA) WAS ADMINISTERED TODAY 5/1/2023, WHICH WAS GIVEN BEFORE THE MINIMUM 2 MONTH INTERVAL. CDC HOTLINE WAS CONTACTED AND RN WAS INFORMED THAT THE DOSE WOULD NEED TO BE REPEATED WITH A 2 MONTH INTERVAL STARTING TODAY WHEN THE INCORRECT DOSE WAS GIVEN. PATIENT WAS INFORMED AND AGREED TO COME IN FOR REPEAT DOSE 2 MONTHS FROM NOW.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- NO
- Andere Medikamente
- UNKNOWN
- Allergien
- NO ALLERGIES TO PREVIOUS COVID VACCINE
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 24.04.2023
- Impfdatum
- 21.10.2022
- Beginn
- 18.12.2022
- Tage bis Beginn
- 58,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Chest X-ray normal
Cough
Lethargy
Rhinorrhoea
SARS-CoV-2 test positive
Streptococcus test positive
Symptomtext
I had mild symptoms, a small cough. I did a home COVID-19 test, that came back positive. I called my PCP, we discussed my symptoms, she asked if I wanted to take the PAXLOVID, I told her no I wasn't interested in it. It took two weeks for the lethargy to go away but I feel great now. In March I had a runny nose, hacking cough. I went to urgent care; they tested me for strep throat and took chest x-rays. The test for strep came back positive, the chest x-rays came back negative. I was given an antibiotic; it took three weeks to get the strep out of my system.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 20DEC2022 home COVID-19 test, positive; 00MAR2023 Strep Throat, positive; 00MAR2023 Chest X-ray, negative
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Hyperlipidemia
- Andere Medikamente
- LIPITOR
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 06.03.2023
- Impfdatum
- 24.02.2023
- Beginn
- 24.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Wrong product administered
Symptomtext
No adverse event; A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series) and NO ADVERSE EVENT (No adverse event) in a 14-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Feb-2023, after starting , the patient experienced WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series). No concomitant medication was reported. A patient was administered a Moderna bivalent booster dose on 24-Feb-2023, before she got the primary series. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 03.03.2023
- Impfdatum
- 02.12.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 03.03.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 03.03.2023
- Impfdatum
- 21.07.2022
- Beginn
- 21.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 03.03.2023
- Impfdatum
- 02.12.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 03.03.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 03.03.2023
- Impfdatum
- 30.01.2022
- Beginn
- 30.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 02.12.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 02.12.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 02.12.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 01.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 01.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 86,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 28.11.2022
- Beginn
- 28.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 01.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 01.03.2023
- Impfdatum
- 01.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 01.03.2023
- Impfdatum
- 15.11.2022
- Beginn
- 03.01.2023
- Tage bis Beginn
- 49,0
- Dosis
- 5
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough Case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Covid + on 01/03/2023
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 28.02.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SC / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 28.02.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 28.02.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 27.02.2023
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 17.02.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient received a second Bivalent booster for COVID-19. CDC only recommends one bivalent booster. MD on site evaluated the patient, no current harm. Will continue to follow and monitor. Dose 0.5 ml. Moderna manufacturer.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- hypothyroid
- Andere Medikamente
- Clozapine 250 mg bedtime. Bisacodyl 5 mg PRN. Synthroid 50mcg daily. Tylenol 650 mg PRN. Melatonin 3 mg bedtime. Depakote 750 mg delayed bedtime. Vitamin D3 50 mcg daily. Miralax 1 packet 17 gm PRN. Risperdal 2.5 mg twice daily.
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 07.02.2023
- Impfdatum
- 07.11.2022
- Beginn
- 18.01.2023
- Tage bis Beginn
- 72,0
- Dosis
- 5
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Balance disorder
Computerised tomogram normal
Hypoaesthesia
Limb discomfort
Magnetic resonance imaging normal
Symptomtext
I received my 5th dose of Moderna Bivalent on 11/07/2022. My adverse event started on 01/18/2023 at 05:00PM in the evening. I was walking out I noticed my foot was heavy. I felt my toes were numb. I had balance issue. I also noticed on my left hand it was numb. I went to the urgent care at 06:00PM. I had a CT scan and MRI on that day. It was normal. The doctor said it was a possible TIA. He wanted me to follow up the next day for a neuro exam. She wanted me to see a neurologist but she hasn't set up an appointment yet. I have a doctor's appointment on 02/15/2023. If I have any balance issue they said to call 911.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Balance disorder
- Hospital-Tage
- -
- Labordaten
- 07FEB2023 CT scan test normal; 07FEB2023 MRI test negative
- Aktuelle Erkrankungen
- COVID-19 infection
- Vorgeschichte
- High Blood Pressure; Thyroid; Cholesterol
- Andere Medikamente
- Levothyroxine; sertraline; lovastatin; amlodipine; calcium; coQ10; multivitamins
- Allergien
- MACROBID
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 30.01.2023
- Impfdatum
- 28.10.2022
- Beginn
- 23.01.2023
- Tage bis Beginn
- 87,0
- Dosis
- 5
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
Breakthrough case admission after 5 vaccines 3/17/21 ModernaLot# 038A21A; Moderna 4/14/21 Lot# 037B21A; Pfizer 10/1/21 Lot# EW0186' Modern 12/22/21 Lot# 066H21A; Moderna 10/28/22 Lot# 051D22A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 26.01.2023
- Impfdatum
- 26.01.2023
- Beginn
- 26.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient received an extra bi-valent booster vaccine. His vaccine card was marked as "Pfizer 10/04/2022" rather than "Pfizer Bivalent 10/04/2022". Therefore, we knew he was 2 months out from his last dose, but it was Pfizer bivalent rather than monovalent.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 45,0
- Geschlecht
- F
- Eingang
- 23.01.2023
- Impfdatum
- 21.10.2022
- Beginn
- 25.12.2022
- Tage bis Beginn
- 65,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Ear infection
Respiratory tract congestion
Upper respiratory tract infection
Symptomtext
I did not have an adverse reaction to the vaccine. I got sick with an upper respiratory infection on 12/25/2022. I also had double ear infection too. I had three virtual medical office visits and I saw my prior doctor. I was given antibiotics for the respiratory infection and ear infection. As of today, I still have some congestion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ear infection
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Obesity
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 23.01.2023
- Impfdatum
- 20.01.2023
- Beginn
- 20.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
I was providing Moderna Bivalent Vaccines to our Hemodialysis patients when they are here for patient convenience. Patient had been asked if he would like to receive the Moderna Bivalent booster on Friday - January 20th. He said he wanted the vaccine. Asked the patient is he had received the Bivalent booster to which he stated "no". This patient is alert and oriented x4. I had spoke with this patient the week of January 9th to offer him a Bivalent vaccine which we chose to wait to administer as he had just recovered from Influenza. When I was documenting the vaccine in our EMR and checking that the documentation went to all the appropriate screens, I noted in the immunization record that he had received a vaccine on January 17th. The patient has not had any adverse reactions. I notified both the unit and his primary care provider.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HD patient
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 20.01.2023
- Impfdatum
- 27.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient was given Moderna Bivalent vaccine when she should have received the Moderna Monovalent vaccine. She denies any adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Migraines
- Andere Medikamente
- Yes
- Allergien
- Moxifloxacin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 20.01.2023
- Impfdatum
- 01.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
No adverse event
Symptomtext
no reaction patient administered 2.5ml instead of full dose .5 ml. patient was called and given the other half of the dose on friday January 20,2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 11.01.2023
- Impfdatum
- 20.10.2022
- Beginn
- 06.01.2023
- Tage bis Beginn
- 78,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immunodeficiency
Symptomtext
Elderly ES to inpatient MedSurg - Immunocompromised No history of Evusheld per EMR Bivalent boost 10/2022
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunodeficiency
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 30.12.2022
- Impfdatum
- 09.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Menstruation irregular
Vaginal haemorrhage
Symptomtext
Vaginal Bleeding / (Early) Menstruation Lasted for 5 days It began earlier than would be expected, I typically have bleeding every 2 months since beginning use of the IUD, I'd had bleeding 2 weeks before the vaccination date already.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Menstruation irregular
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Dysmenorrhea ADHD Major Deppressive Disorder Generalized Anxiety Disorder
- Andere Medikamente
- Velafaxine 225mg Adderall 15mg XR Mirena IUD
- Allergien
- None
- Vorherige Impfungen
- Early Menstruation following 1st Covid Booster
- Staat
- -
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 29.12.2022
- Impfdatum
- 27.12.2022
- Beginn
- 28.12.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Symptomtext
he gave a booster dose to patient instead of the 1st COVID vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 23.12.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Poor quality product administered
Product temperature excursion issue
Symptomtext
HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.; HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.; Poor quality vaccine administered; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.), PRODUCT TEMPERATURE EXCURSION ISSUE (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) in an 87-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Second dose) on 25-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE (First booster (Third dose)) on 06-Dec-2021 and PFIZER BIONTECH COVID-19 VACCINE (First dose) until 04-Mar-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. Concurrent medical conditions included Prostate cancer, Chronic kidney disease stage 3 and Coronary artery disease. On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.), PRODUCT TEMPERATURE EXCURSION ISSUE (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.), PRODUCT TEMPERATURE EXCURSION ISSUE (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.), PRODUCT TEMPERATURE EXCURSION ISSUE (HCP stated a patient was vaccinated with Moderna COVID-19 Vaccine Bivalent after the vial spend more than 24 hours at room temperature. The vaccine was exposed to room temperature since 16Dec2022 at 4:30 PM to 19Dec2022 at 9 AM.) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered). No concomitant medications details were reported. Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Caller mentioned no AEs were reported. Moderna was authorized to communicate with the vaccine recipient's primary healthcare professional regarding notification. No treatment medications details were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Chronic kidney disease stage 3; Coronary artery disease; Prostate cancer
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 15.12.2022
- Beginn
- 15.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in an 86-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: COVID-19 VACCINE on 04-Mar-2021, COVID-19 VACCINE on 01-Apr-2021, COVID-19 VACCINE on 04-Nov-2021 and COVID-19 VACCINE. Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE, COVID-19 VACCINE, COVID-19 VACCINE and COVID-19 VACCINE. On 15-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 15-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). NO Concomitant medication was provided by reporter. No Treatment medication was provided by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WY
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 20.12.2022
- Impfdatum
- 19.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- -
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
No adverse event
Symptomtext
Patient received second bivalent rx by mistake; no adverse effects noted
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Post kidney pancreas transplant High blood pressure High cholesterol Thyroid disorder Gerd
- Andere Medikamente
- Tacrolimus Mycophenolate Prednisone Creon Cholestyramine Calcitonin Levothyroxine Metoprolol Pantoprazole Olmesartanatorvastatin
- Allergien
- Codeine Promethazine Diphenhydramine
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 14.12.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; No adverse event; bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Allergies to medication, food and other products were unknown. It was unknown if the patient had ever been diagnosed or tested positive for COVID-19. Chronic and acute illness at the time of vaccination and one month prior was unknown. On 18-Nov-2022 at 8:00 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 18-Nov-2022 at 8:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related and EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022) to have an unknown relationship. No further causality assessment was provided for PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022). On 11-Dec-2021, patient received third dose of Moderna COVID-19 vaccine (intramuscular). On 01-May-2021, patient received second dose of Moderna COVID-19 vaccine (intramuscular). On 03-Apr-2021, patient received first dose of Moderna COVID-19 vaccine (intramuscular). Prescriptions, over the counter medications, dietary supplements or herbal medicines being taken at the time of vaccination and or at the time of adverse event was unknown. It was reported that 14 doses of the bivalent Moderna COVID-19 vaccine were given after the beyond use date BUD. Individual vials of vial size 2.5ml. The vial was initially stored in the refrigerator on 18-Oct-2022. The vial had not undergone any temperature excursions. The event had not caused patient to seek medical care. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675238:same reporter US-MODERNATX, INC.-MOD-2022-675258:same reporter US-MODERNATX, INC.-MOD-2022-675259:same reporter US-MODERNATX, INC.-MOD-2022-675260:same reporter US-MODERNATX, INC.-MOD-2022-675261:same reporter US-MODERNATX, INC.-MOD-2022-675262:same reporter US-MODERNATX, INC.-MOD-2022-675263:same reporter US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675265:same reporter US-MODERNATX, INC.-MOD-2022-675266:same reporter US-MODERNATX, INC.-MOD-2022-675268:same reporter US-MODERNATX, INC.-MOD-2022-675269:same reporter US-MODERNATX, INC.-MOD-2022-675270:same reporter US-MODERNATX, INC.-MOD-2022-675271:same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: Allergies to medication, food and other products were unknown. It was unknown if the patient had ever been diagnosed or tested positive for COVID-19. Chronic and acute illness at the time of vaccination and one month prior was unknown.
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 10.12.2022
- Impfdatum
- 09.12.2022
- Beginn
- 09.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
Patient was inadvertently administered Moderna Covid-19 Bivalent Vaccine despite patient having never received any primary series doses of Covid-19 vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 98,0
- Geschlecht
- M
- Eingang
- 10.12.2022
- Impfdatum
- 16.11.2022
- Beginn
- 06.12.2022
- Tage bis Beginn
- 20,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Symptomtext
Pt has shingles beginning 3 weeks after booster vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Herpes zoster
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- congestive heart failure Atrial fib/flutter dementia Renal insufficiency
- Andere Medikamente
- lipitor. torsemide. Potassium chloride. metoprolol famotidine polyetheline glycol acetominophen Multivitamins senosides
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 08.12.2022
- Impfdatum
- 20.10.2022
- Beginn
- 12.11.2022
- Tage bis Beginn
- 23,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: ja
ER: unbekannt
Erholt: nein
Deafness neurosensory
Deafness unilateral
Sudden hearing loss
Symptomtext
Sudden sensorineural hearing loss with profound hearing loss in the right ear on 11/12/22. Pt was given a prednisone burst without recovery. Receiving series of intratympanic steroid injections currently. Poor prognosis for recovery
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Deafness neurosensory
- Hospital-Tage
- -
- Labordaten
- Prednisone 11/17 - 11/30
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 08.12.2022
- Impfdatum
- 25.10.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 16,0
- Dosis
- 5
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Cough
Dry throat
Nasal disorder
SARS-CoV-2 test positive
Sneezing
Symptomtext
November 10, 2022 my throat was dry on November 11 2022 I started sneezing, coughing, blowing my nose which continued through the 13th of November 2022. A rapid COVID-19 test resulted in a positive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID-19 test result was positive.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD
- Andere Medikamente
- B12 vitamin; vitamin D3; zinc complex; ZYRTEC; hydrochlorothiazide; lisinopril
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 01.12.2022
- Impfdatum
- 01.12.2022
- Beginn
- 01.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Incorrect product formulation administered
Symptomtext
Patient made appointment for Moderna Bivalent Booster. When she arrived she confirmed she was looking for Bivalent Booster. After administration of the IMZ and reporting to our immunization registry, it was discovered she was due for a second dose of the primary series with her first dose being 11 months ago. No adverse issues reported by patient. CDC was called for info and suggestion to offer pt the second dose was given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 30.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 22,0
- Dosis
- 5
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test
Weight
Symptomtext
Covid-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Covid-19) in a 75-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for Autoimmune disorder NOS. Concurrent medical conditions included Atrial fibrillation (A-fib), Lupus syndrome (Lupus) and Blood cholesterol abnormal (Cholesterol). Concomitant products included RIVAROXABAN (XARELTO) for Atrial fibrillation, ROSUVASTATIN for Cholesterol, HYDROXYCHLOROQUINE for Lupus syndrome. On 28-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Nov-2022, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Nov-2022, SARS-CoV-2 test: Positive. On an unknown date, Weight: Increased. Patient received 1st dose on 15Jan2021 with Lot: 012L20A; 2nd dose on 16Feb2021 with Lot: 010M20A; 3rd dose on 25Oct2021 with Lot: 032F21A and 4th dose on 18Apr2022 with Lot: 005M21A. Patient was allergic to a lot of things, so she had to wait the 30 minutes after 1st dose, but she was fine. Patient had all her injection and booster. Patient had not taken any of the Paxlovid at the time of this report. Her symptoms started Saturday but she thought she just had a cold because all she really had was a runny nose. Patient was much thinner when COVID pandemic had started however being home all the time and not doing anything she had put on a lot of weight. Patient was in the hospital the previous weekend and she believed that's where she had picked up the COVID-19. Patient was diagnosed with COVID-19 after receiving 5 doses of the Moderna Covid Vaccine. It was reported that the packaging was sealed and intact. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- Test Date: 20221120; Test Name: Covid-19 self test; Test Result: Positive ; Test Name: Lot of weight; Result Unstructured Data: Increased
- Aktuelle Erkrankungen
- Atrial fibrillation (A-fib); Blood cholesterol abnormal (Cholesterol); Lupus syndrome (Lupus)
- Vorgeschichte
- -
- Andere Medikamente
- XARELTO; HYDROXYCHLOROQUINE; ROSUVASTATIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 27.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 31.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 23.11.2022
- Impfdatum
- 19.11.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Needle issue
Symptomtext
Error: Wrong Needle Length-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Needle issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vial initially stored in refrigerator on 18 oct 2022; No adverse event; bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 18 oct 2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 18 oct 2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 18 oct 2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 18 oct 2022). 14 doses of the bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022 No concomitant medications were reported. Vial size was reported as 2.5ml On 18Oct2022, the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions. No treatment medications were reported. This case contains information for the 14th of 14 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260:Patient 14 US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675268:Patient 14 US-MODERNATX, INC.-MOD-2022-675269: US-MODERNATX, INC.-MOD-2022-675259:Patient 14 US-MODERNATX, INC.-MOD-2022-675270:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
vaccine were given after the beyond use date BUD 17Nov2022, administration of vaccine on 18Nov2022; No adverse event; bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (vaccine were given after the beyond use date BUD 17Nov2022, administration of vaccine on 18Nov2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine were given after the beyond use date BUD 17Nov2022, administration of vaccine on 18Nov2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (vaccine were given after the beyond use date BUD 17Nov2022, administration of vaccine on 18Nov2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) and PRODUCT STORAGE ERROR (vaccine were given after the beyond use date BUD 17Nov2022, administration of vaccine on 18Nov2022). No concomitant medication were reported. 14 doses of the bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022. Bivalent vaccine. Individual vials with Vial size of 2.5 mL. The vial was initially stored in the refrigerator on 18-Oct-2022. Vaccine was administered on 18-Nov-2022. No treatment information was provided by the reporter. This case was for 13th patient of 14 patients. This case was linked to MODERNATX, INC.-MOD-2022-675260, MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675271 (E2B Linked Report); Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260:patient 4; US-MODERNATX, INC.-MOD-2022-675264:patient 8; US-MODERNATX, INC.-MOD-2022-675268:Patient 11; US-MODERNATX, INC.-MOD-2022-675269:patient 12; US-MODERNATX, INC.-MOD-2022-675259:patient 3; US-MODERNATX, INC.-MOD-2022-675238:patient 1 US-MODERNATX, INC.-MOD-2022-675258:patient 2; US-MODERNATX, INC.-MOD-2022-675261:patient 5 US-MODERNATX, INC.-MOD-2022-675262:patient 6; US-MODERNATX, INC.-MOD-2022-675263:patient 7 US-MODERNATX, INC.-MOD-2022-675265:patient 9; US-MODERNATX, INC.-MOD-2022-675266:patient 10 US-MODERNATX, INC.-MOD-2022-675271:patient 14
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; No adverse event; bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022). No concomitant medications were reported. An individual vial of 2.5 ml was initially stored in the refrigerator on 18-Oct-2022. The vial did not undergo any temperature excursions. No treatment medications were reported. This case contains information for the 12th of 14 adults patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675264: US-MODERNATX, INC.-MOD-2022-675260: US-MODERNATX, INC.-MOD-2022-675268: US-MODERNATX, INC.-MOD-2022-675259: US-MODERNATX, INC.-MOD-2022-675238: US-MODERNATX, INC.-MOD-2022-675258: US-MODERNATX, INC.-MOD-2022-675261: US-MODERNATX, INC.-MOD-2022-675262: US-MODERNATX, INC.-MOD-2022-675263: US-MODERNATX, INC.-MOD-2022-675265: US-MODERNATX, INC.-MOD-2022-675266: US-MODERNATX, INC.-MOD-2022-675270: US-MODERNATX, INC.-MOD-2022-675271:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022; No adverse event; Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022) and PRODUCT STORAGE ERROR (Patient received bivalent Moderna COVID19 vaccine after the beyond use date BUD 17Nov2022). No concomitant medications were reported. Vial size was reported as 2.5ml The vial was initially stored in the refrigerator on 18-Oct-2022. The via did not undergo any temperature excursions. Beyond use date was reported as 17-Nov-2022. No treatment medications were reported. This case contains information for the 10th of 14th adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260: US-MODERNATX, INC.-MOD-2022-675268: US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675269: US-MODERNATX, INC.-MOD-2022-675259: US-MODERNATX, INC.-MOD-2022-675270:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vial was initially stored in refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; No adverse event; bivalent Moderna COVID19 vaccine given after the beyond use date BUD 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine given after the beyond use date BUD 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine given after the beyond use date BUD 17-Nov-2022) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022). Concomitant drugs were not reported. It was reported that the individual vials of 2.5 ml size did not underwent any temperature excursion. Treatment medications were not provided. This case was reported for Adult patient 5. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260:Patient 5 US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675268:Patient 5 US-MODERNATX, INC.-MOD-2022-675269: US-MODERNATX, INC.-MOD-2022-675270: US-MODERNATX, INC.-MOD-2022-675259:Patient 5
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022; Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022). No concomitant medications were provided. There was individual vial and vial size was 2.5ml. The vial was initially stored in the refrigerator on 18-Oct-2022 The vial did not undergo any temperature excursions. No treatment medication was provided. This case contains information for the 3rd of 14 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675238:Patient 1 US-MODERNATX, INC.-MOD-2022-675258:Patient 2 US-MODERNATX, INC.-MOD-2022-675260:Patient 4 US-MODERNATX, INC.-MOD-2022-675261:Patient 5 US-MODERNATX, INC.-MOD-2022-675262:Patient 6 US-MODERNATX, INC.-MOD-2022-675263:Patient 7 US-MODERNATX, INC.-MOD-2022-675264:Patient 8 US-MODERNATX, INC.-MOD-2022-675265:Patient 9 US-MODERNATX, INC.-MOD-2022-675266:Patient 10 US-MODERNATX, INC.-MOD-2022-675268:Patient 11 US-MODERNATX, INC.-MOD-2022-675269:Patient 12 US-MODERNATX, INC.-MOD-2022-675270:Patient 13 US-MODERNATX, INC.-MOD-2022-675271:Patient 14
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; no adverse event; Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022). No concomitant medications were provided. The vial size was 2.5ml. The vial was initially stored in the refrigerator on 18-Oct-2022 The vial did not undergo any temperature excursions. No treatment medication was provided. This case contains information for the 2nd of 14 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260:Patient 4 US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675259:Patient 3 US-MODERNATX, INC.-MOD-2022-675268:Patient 11 US-MODERNATX, INC.-MOD-2022-675269:Patient 12 US-MODERNATX, INC.-MOD-2022-675270:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; No adverse event; Bivalent Moderna COVID19 vaccine were given after the beyond use date of 17Nov2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date of 17Nov2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date of 17Nov2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date of 17Nov2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date of 17Nov2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022). No concomitant medications were reported. It was reported that total 14 doses of Bivalent vaccines were administered beyond use date. There were Individual vials of size 2.5 ml. The vial was initially stored in the refrigerator on 18-Oct-2022. The vial did not undergo any temperature excursions. No treatment details were reported. This case contains information of the 11 of 14 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271, US-MODERNATX, INC.-MOD-2022-675259 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675238:Patient 1 US-MODERNATX, INC.-MOD-2022-675258:Patient 2 US-MODERNATX, INC.-MOD-2022-675260:Patient 4 US-MODERNATX, INC.-MOD-2022-675261:Patient 5 US-MODERNATX, INC.-MOD-2022-675262:Patient 6 US-MODERNATX, INC.-MOD-2022-675264:Patient 8 US-MODERNATX, INC.-MOD-2022-675265:Patient 9 US-MODERNATX, INC.-MOD-2022-675266:Patient 10 US-MODERNATX, INC.-MOD-2022-675269:Patient 12 US-MODERNATX, INC.-MOD-2022-675270:Patient 13 US-MODERNATX, INC.-MOD-2022-675271:Patient 14
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022; No adverse event; Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022). Concomitant medication was not provided. Reporter reported that the vial was individual vial and size was 2.5 ml. The vial was initially stored in the refrigerator on 18-oct-2022. The vial did not undergo any temperature excursions. Treatment information was not provided. This case contains information for the 9th of 14 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260: US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675268:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.; No adverse event; Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date 17-Nov-2022) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.). No concomitant medications were reported. Vial size was reported as 2.5mL.Vial was initially stored in the refrigerator on 18-Oct-2022.Vaccine use by date was 17-NOV-2022. Vial did not undergo any temperature excursions. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260:Patient 8 US-MODERNATX, INC.-MOD-2022-675238:Patient 1, same reporter US-MODERNATX, INC.-MOD-2022-675258:Patient 2, same reporter US-MODERNATX, INC.-MOD-2022-675259:Patient 3, same reporter US-MODERNATX, INC.-MOD-2022-675261:same reporter US-MODERNATX, INC.-MOD-2022-675262:same reporter US-MODERNATX, INC.-MOD-2022-675263:same reporter US-MODERNATX, INC.-MOD-2022-675265:same reporter US-MODERNATX, INC.-MOD-2022-675266:same reporter US-MODERNATX, INC.-MOD-2022-675268:same reporter US-MODERNATX, INC.-MOD-2022-675269:same reporter US-MODERNATX, INC.-MOD-2022-675270:same reporter US-MODERNATX, INC.-MOD-2022-675271:same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
vial was initially stored in the refrigerator on 18-Oct-2022, before use date was 17-Nov-2022, the administration of vaccine was on 18-Nov-2022.; No adverse event; bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 18-Oct-2022, before use date was 17-Nov-2022, the administration of vaccine was on 18-Nov-2022.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 18-Oct-2022, before use date was 17-Nov-2022, the administration of vaccine was on 18-Nov-2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 18-Oct-2022, before use date was 17-Nov-2022, the administration of vaccine was on 18-Nov-2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 18-Oct-2022, before use date was 17-Nov-2022, the administration of vaccine was on 18-Nov-2022.). No concomitant drug was reported. The vial size was reported as 2.5 ml. The vial was initially stored in the refrigerator on 18-Oct-2022, before use date was 17-Nov-2022, the administration of vaccine was on 18-Nov-2022. It was reported that the vial did not undergo any temperature excursions. No treatment drug was reported. This case contains information for the 7th of 14 adult patients described by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.; No adverse event; bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 18-Oct-2022, vaccine use by date was 17-NOV-2022,dose was administered on 18-NOV-2022.). No concomitant medications were reported. Vial size was reported as 2.5mL.Vial was initially stored in the refrigerator on 18-Oct-2022.Vaccine use by date was 17-NOV-2022. Vial did not underwent any temperature excursions. No treatment information was provided. This case was reported for adult patient 6 out of 14 patients. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260:Patient 6 US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675268:Patient 6
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; No adverse event; Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022). No concomitant medications were provided. The vial size was 2.5ml. The vial was initially stored in the refrigerator on 18-Oct-2022 The vial did not undergo any temperature excursions. No treatment medication was provided. This case contains information for the 4th of 14 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675259, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675238:Patient 1 US-MODERNATX, INC.-MOD-2022-675258:Patient 2 US-MODERNATX, INC.-MOD-2022-675259:Patient 3 US-MODERNATX, INC.-MOD-2022-675261:Patient 5 US-MODERNATX, INC.-MOD-2022-675262:Patient 6 US-MODERNATX, INC.-MOD-2022-675263:Patient 7 US-MODERNATX, INC.-MOD-2022-675264:Patient 8 US-MODERNATX, INC.-MOD-2022-675265:Patient 9 US-MODERNATX, INC.-MOD-2022-675266:Patient 10 US-MODERNATX, INC.-MOD-2022-675269:Patient 12 US-MODERNATX, INC.-MOD-2022-675270:Patient 13 US-MODERNATX, INC.-MOD-2022-675271:Patient 14
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 23.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
the vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022; No adverse event; bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 18-Oct-2022 and vaccine administered on 18-Nov-2022). No concomitant medication details was reported. It was reported that individual vails was used and vial size was reported as 2.5ml. The vial did not undergo any temperature excursions. No treatment medication details was reported. This case contains information for the 1st of 14 adult patients described by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675268 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-675260:Patient 1 US-MODERNATX, INC.-MOD-2022-675264:same reporter US-MODERNATX, INC.-MOD-2022-675268:Patient 1
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 22.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 18.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 16.11.2022
- Impfdatum
- 04.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Joint swelling
Peripheral swelling
Symptomtext
Please, report that pt had swelling of her forearm, for months , MOderna , unusual swelling over left forearm and wrist , wrist lasted for few days ,a nd forearm of the arm where she got vaccine last time lasted for months, and now she got it again, recently, few months ago, has swelling of soft tissue over elbow area,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Joint swelling
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Pt had swelling of her forearm, for months , MOderna , unusual swelling over left forearm and wrist , wrist lasted for few days ,a nd forearm of the arm where she got vaccine last time lasted for months, and now she got it again, recently, few months ago, has swelling of soft tissue over elbow area,
- Vorgeschichte
- J45.20 Mild intermittent asthma R73.03 Prediabetes D51.0 Vitamin B12 deficiency anemia E55.0 Vitamin D deficiency F41.9 Anxiety disorder G47.09 Other insomnia G47.33 Obstructive sleep apnea M54.12 Radiculopathy, cervical region Z68.35 Body mas index [BMI] 35.0-35.9
- Andere Medikamente
- Alprazolam 0.25mg Cyclobenzaprine 10 mg Diclofenac sodium 50 mg Famciclovir 500 mg Lunesta 3 mg Methocarbamol 500 mg Multivitamin Pantoprazole 40 mg Patanol 01.% opthalmic solution ProAir HFA 90 cmg/actuation inhalation scopolamine base 1 m
- Allergien
- Penicillins Vancomycin HCL Vitamin D CLotrimazole Nystatin
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 16.11.2022
- Impfdatum
- 14.11.2022
- Beginn
- 14.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient was never vaccinated for COVID-19. Came into the office for a first time COVID vaccine, and was mistakenly given the Moderna Bivalent Booster vaccine, instead of the Monovalent (which we do not carry)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- NO
- Andere Medikamente
- NO
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 16.11.2022
- Impfdatum
- 14.11.2022
- Beginn
- 14.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient was never vaccinated for COVID-19. Came into the office for a first time COVID vaccine, and was mistakenly given the Moderna Bivalent Booster vaccine, instead of the Monovalent (which we do not carry)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 09.11.2022
- Impfdatum
- 05.11.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 05.11.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
Error: Improper Storage (ex. temp./location)-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 05.11.2022
- Beginn
- 05.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Error: Dose in Series Given Too Early-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 08.11.2022
- Impfdatum
- 04.11.2022
- Beginn
- 04.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Syringe issue
Underdose
Symptomtext
No adverse event; some dose leaked out of the syringe; some dose leaked out of the syringe; This spontaneous case was reported by a pharmacist and describes the occurrence of SYRINGE ISSUE (some dose leaked out of the syringe), UNDERDOSE (some dose leaked out of the syringe) and NO ADVERSE EVENT (No adverse event) in a 70-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Nov-2022, the patient experienced SYRINGE ISSUE (some dose leaked out of the syringe) and UNDERDOSE (some dose leaked out of the syringe). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, SYRINGE ISSUE (some dose leaked out of the syringe), UNDERDOSE (some dose leaked out of the syringe) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for SYRINGE ISSUE (some dose leaked out of the syringe) and UNDERDOSE (some dose leaked out of the syringe). No concomitant medications were reported. The pharmacist stated that they were trying to administer Moderna bivalent 0.5 ml, but some dose leaked out of the syringe. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 07.11.2022
- Impfdatum
- 06.11.2022
- Beginn
- 07.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
possible give out o series possible booster give prior to completion of initial series
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 04.11.2022
- Impfdatum
- 03.11.2022
- Beginn
- 03.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient received bivalent dose >12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received bivalent dose >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received bivalent dose >12 hours post puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received bivalent dose >12 hours post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received bivalent dose >12 hours post puncture). No concomitant medication was reported. Date the vial was initially stored in the refrigerator on 02-Nov-2022. Date and time vial was first punctured on 02-Nov-2022 at 4pm. The time of administration of vaccine was around 10 o'clock. The vial did not undergo any temperature excursions. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 03.11.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
Patient received a second bivalent dose and it was a Moderna Bivalent; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (Patient received a second bivalent dose and it was a Moderna Bivalent) and NO ADVERSE EVENT (No adverse event) in an 89-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer on 15-Oct-2022. Past adverse reactions to the above products included No adverse event with Pfizer. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Patient received a second bivalent dose and it was a Moderna Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (Patient received a second bivalent dose and it was a Moderna Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (Patient received a second bivalent dose and it was a Moderna Bivalent). No concomitant information was reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 02.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Underdose
Symptomtext
No adverse event; Half dose; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Half dose) and NO ADVERSE EVENT (No adverse event) in a 72-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer on 12-Mar-2021 and Pfizer on 02-Apr-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. Concurrent medical conditions included Immunocompromised. On 28-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 28-Oct-2022, the patient experienced UNDERDOSE (Half dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Half dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Half dose). The concomitant medication was not reported by reporter. On 03-Jun-2022, patient received intramuscular Moderna vaccine injection (lot number 037A22B, expiration date 31-Aug-2022). The dose given on the day of the report by intramuscular injection was a 0.25mL dose. The patient requested this dose because patient was immunocompromised. No reported symptoms. No additional doses, medications, or treatments reported. The treatment medication was not reported by reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Immunocompromised
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 30.10.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Syringe issue
Symptomtext
Error: Leaking from Syringe-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syringe issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 30.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 30.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 97,0
- Geschlecht
- F
- Eingang
- 30.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Error: Expired Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product storage error
Product temperature excursion issue
Symptomtext
Bivalent dose administered to patient after temperature excursion; Returned vial to the refrigerator after administering, which undergone temperature excursion with highest at 46.5 F for 15 minutes; No adverse event; Bivalent dose administered to patient after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion), PRODUCT STORAGE ERROR (Returned vial to the refrigerator after administering, which undergone temperature excursion with highest at 46.5 F for 15 minutes) and NO ADVERSE EVENT (No adverse event) in an 82-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. No Medical History information was reported. On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 24-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion), PRODUCT STORAGE ERROR (Returned vial to the refrigerator after administering, which undergone temperature excursion with highest at 46.5 F for 15 minutes) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion), PRODUCT STORAGE ERROR (Returned vial to the refrigerator after administering, which undergone temperature excursion with highest at 46.5 F for 15 minutes) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion) and PRODUCT STORAGE ERROR (Returned vial to the refrigerator after administering, which undergone temperature excursion with highest at 46.5 F for 15 minutes). The concomitant medication was not reported by reporter. It was reported that vaccine underwent a temperature excursion on Friday 21Oct2022. Storage condition at the time of the excursion was refrigerated. The vaccine was an individual vial. The size of the vial was 2.5mL. The highest temperature reached was 46.5 F. The excursion duration was 15 minutes. The vials were returned to the refrigerator. The vaccines appeared normal during visual inspection. The Lot numbers and Expiration Dates of the vaccines that underwent temperature excursion were 051D22A,083B22A and 19-Nov2022 and 28-Nov-2022 respectively. The treatment medication was not reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-664063, US-MODERNATX, INC.-MOD-2022-664049, US-MODERNATX, INC.-MOD-2022-664054, US-MODERNATX, INC.-MOD-2022-664064, US-MODERNATX, INC.-MOD-2022-664045, US-MODERNATX, INC.-MOD-2022-664042 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-664064:Same reporter US-MODERNATX, INC.-MOD-2022-664049:Same reporter US-MODERNATX, INC.-MOD-2022-664045:Same reporter US-MODERNATX, INC.-MOD-2022-664054:Same reporter US-MODERNATX, INC.-MOD-2022-664063:Same reporter US-MODERNATX, INC.-MOD-2022-664042:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 27.10.2022
- Beginn
- 27.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood glucose increased
Symptomtext
Patient received their moderna bivalent booster on 10/27/22 at 3:05pm. By that evening the patient, who has diabetes, tested their BG and noticed that it was ~280, which is higher than normal. The patient then waiting and tested again the morning of 10/28/22 and their BG had only dropped to ~272, which again was quite a bit higher than normal, especially for them to be fasting. The daughter was concerned and called us to ask if that was normal. We informed her that it was most likely due to the covid booster and that that is not a normal vaccination symptom. We advised her to check her BG more often than normal and call her doctor to let them know of the situation to see if they would like her to be seen. Spoke with the patient's daughter several hours later on 10/28/22 and they had called the patient's doctor and the MD just wanted them to keep an eye on her sugars and to let them know of any changes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blood glucose increased
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Diabetes
- Andere Medikamente
- Unknown.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 28.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product storage error
Product temperature excursion issue
Symptomtext
Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes; No adverse event; Bivalent dose administered to 7 patient after temperature excursion; Bivalent dose administered to 7 patient after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 76-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. No Medical History information was reported. On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 21-Oct-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion). On 24-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion). The concomitant medication was not reported by reporter. It was reported that vaccine underwent a temperature excursion on Friday 21-Oct-2022.Storage condition at the time of the excursion was refrigerated. The vaccine was an individual vial. The size of the vial was 2.5mL. The highest temperature reached was 46.5 F. The excursion duration was 15 minutes. The vials were returned to the refrigerator. The vaccines appeared normal during visual inspection. The Lot numbers and Expiration Dates of the vaccines that underwent temperature excursion were 083B22A, 051D22A and 28-Nov-2022 and 19-Nov-2022 respectively. The treatment medication was not reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-664063, US-MODERNATX, INC.-MOD-2022-664049, US-MODERNATX, INC.-MOD-2022-664054, US-MODERNATX, INC.-MOD-2022-664042, US-MODERNATX, INC.-MOD-2022-664045, US-MODERNATX, INC.-MOD-2022-664056 (E2B Linked Report). Sender's Comments: US-MODERNATX, INC.-MOD-2022-664063:Same reporter US-MODERNATX, INC.-MOD-2022-664049:Same reporter US-MODERNATX, INC.-MOD-2022-664054:Same reporter US-MODERNATX, INC.-MOD-2022-664042:Same reporter US-MODERNATX, INC.-MOD-2022-664045:Same reporter US-MODERNATX, INC.-MOD-2022-664056:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product storage error
Product temperature excursion issue
Symptomtext
Bivalent dose administered to patient after temperature excursion.; Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes; No adverse event; Bivalent dose administered to patient after temperature excursion.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion.), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion.) and NO ADVERSE EVENT (No adverse event) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. No Medical History information was reported. On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 24-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion.), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion.), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to patient after temperature excursion.), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to patient after temperature excursion.). The concomitant medication was not reported by reporter. It was reported that vaccine underwent a temperature excursion on Friday 21-Oct-2022.Storage condition at the time of the excursion was refrigerated. The vaccine was an individual vial. The size of the vial was 2.5mL. The highest temperature reached was 46.5 F. The excursion duration was 15 minutes. The vials were returned to the refrigerator. The vaccines appeared normal during visual inspection. The Lot numbers and Expiration Dates of the vaccines that underwent temperature excursion were 083B22A, 051D22A and 28-Nov-2022 and 19-Nov-2022 respectively. The treatment medication was not reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-664063, US-MODERNATX, INC.-MOD-2022-664049, US-MODERNATX, INC.-MOD-2022-664054, US-MODERNATX, INC.-MOD-2022-664064, US-MODERNATX, INC.-MOD-2022-664042, US-MODERNATX, INC.-MOD-2022-664056 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-664064:Same reporter US-MODERNATX, INC.-MOD-2022-664054:Same reporter US-MODERNATX, INC.-MOD-2022-664049:Same reporter US-MODERNATX, INC.-MOD-2022-664063:Same reporter US-MODERNATX, INC.-MOD-2022-664042:Same reporter US-MODERNATX, INC.-MOD-2022-664056:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product storage error
Product temperature excursion issue
Symptomtext
Bivalent dose administered to 7 patient after temperature excursion; Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes; No adverse event; Bivalent dose administered to 7 patient after temperature excursion.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion.) and NO ADVERSE EVENT (No adverse event) in a 41-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. No Medical History information was reported. On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 24-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes), POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and POOR QUALITY PRODUCT ADMINISTERED (Bivalent dose administered to 7 patient after temperature excursion.). The concomitant medication was not reported by reporter. It was reported that vaccine underwent a temperature excursion on Friday 21-Oct-2022.Storage condition at the time of the excursion was refrigerated. The vaccine was an individual vial. The size of the vial was 2.5mL. The highest temperature reached was 46.5 F. The excursion duration was 15 minutes. The vials were returned to the refrigerator. The vaccines appeared normal during visual inspection. The Lot numbers and Expiration Dates of the vaccines that underwent temperature excursion were 083B22A, 051D22A and 28-Nov-2022 and 19-Nov-2022 respectively. The treatment medication was not reported by reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-664042, US-MODERNATX, INC.-MOD-2022-664045, US-MODERNATX, INC.-MOD-2022-664054, US-MODERNATX, INC.-MOD-2022-664056, US-MODERNATX, INC.-MOD-2022-664063, US-MODERNATX, INC.-MOD-2022-664064 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-664042:Same reporter US-MODERNATX, INC.-MOD-2022-664045:Same reporter US-MODERNATX, INC.-MOD-2022-664054:Same reporter US-MODERNATX, INC.-MOD-2022-664056:Same reporter US-MODERNATX, INC.-MOD-2022-664063:Same reporter US-MODERNATX, INC.-MOD-2022-664064:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Maternal exposure during pregnancy
No adverse event
Product storage error
Product temperature excursion issue
Symptomtext
Bivalent dose administered to 7 patient after temperature excursion; No adverse event; Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes; Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes), MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) and NO ADVERSE EVENT (No adverse event) in a 25-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-May-2023. On 24-Oct-2022, the patient experienced PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion) and NO ADVERSE EVENT (No adverse event). On 24-Oct-2022, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved. At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion), PRODUCT STORAGE ERROR (Stored in the refrigerator at the time of the excursion with temperatures highest at 46.5 F for 15 minutes) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). Treatment and concomitant medications were not reported. It was reported that vaccine underwent a temperature excursion on Friday 21-Oct-2022. Vaccines were stored in refrigerator at the time of the excursion. Gestation weeks was unknown. Individual vials size was 2.5mL and expiration date was 19-Nov-2022. Highest temperatures reached was 46.5 F for 15 minutes. It was reported that vials appeared normal. Company Comment: This spontaneous prospective pregnancy case concerns a 25-year-old female patient with no reported medical history, who experienced the unexpected, non-serious events of Maternal exposure during pregnancy and No adverse Event after receiving a dose mRNA-1273.222 Bivalent (Original and Omicron BA.4/BA.5) vaccine. Last menstrual period was not provided. The given estimated date of delivery would approximate gestational age of 13 weeks at the time of vaccine administration. Additionally, Product temperature excursion issue and Product storage error were noted since the patient received a vaccine that underwent temperature excursion (highest at 46.5 F) in the refrigerator for 15 minutes. No information on any other doses of COVID-19 vaccination was provided. The benefit-risk relationship of mRNA-1273.222 Bivalent (Original and Omicron BA.4/BA.5) vaccine is not affected by this report. This case was linked to US-MODERNATX, INC.-MOD-2022-664042, US-MODERNATX, INC.-MOD-2022-664045, US-MODERNATX, INC.-MOD-2022-664049, US-MODERNATX, INC.-MOD-2022-664054, US-MODERNATX, INC.-MOD-2022-664056, US-MODERNATX, INC.-MOD-2022-664064 (E2B Linked Report).; Sender's Comments: This spontaneous prospective pregnancy case concerns a 25-year-old female patient with no reported medical history, who experienced the unexpected, non-serious events of Maternal exposure during pregnancy and No adverse Event after receiving a dose mRNA-1273.222 Bivalent (Original and Omicron BA.4/BA.5) vaccine. Last menstrual period was not provided. The given estimated date of delivery would approximate gestational age of 13 weeks at the time of vaccine administration. Additionally, Product temperature excursion issue and Product storage error were noted since the patient received a vaccine that underwent temperature excursion (highest at 46.5 F) in the refrigerator for 15 minutes. No information on any other doses of COVID-19 vaccination was provided. The benefit-risk relationship of mRNA-1273.222 Bivalent (Original and Omicron BA.4/BA.5) vaccine is not affected by this report. US-MODERNATX, INC.-MOD-2022-664042: US-MODERNATX, INC.-MOD-2022-664045: US-MODERNATX, INC.-MOD-2022-664049: US-MODERNATX, INC.-MOD-2022-664054: US-MODERNATX, INC.-MOD-2022-664056: US-MODERNATX, INC.-MOD-2022-664064:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Maternal exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 28.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product storage error
Product temperature excursion issue
Symptomtext
Product storage error; No adverse event; Poor quality product administered; Bivalent dose administered to 7 patient after temperature excursion.; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion.), PRODUCT STORAGE ERROR (Product storage error), POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and NO ADVERSE EVENT (No adverse event) in a 48-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. No Medical History information was reported. On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 21-Oct-2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion.). On 24-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion.), PRODUCT STORAGE ERROR (Product storage error), POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Bivalent dose administered to 7 patient after temperature excursion.), PRODUCT STORAGE ERROR (Product storage error) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality product administered). Concomitant medications were not reported. Storage condition at the time of the excursion was refrigerated. The vaccine was an individual vial. The size of the vial was 2.5mL. The highest temperature reached was 46.5 F. The excursion duration was 15 minutes. The vials were returned to the refrigerator. The vaccines appeared normal during visual inspection. The Lot numbers and Expiration Dates of the vaccines that underwent temperature excursion were 083B22A, 051D22A and 28Nov2022 and 19Nov2022 respectively. No treatment information provided. This case was linked to US-MODERNATX, INC.-MOD-2022-664063, US-MODERNATX, INC.-MOD-2022-664049, US-MODERNATX, INC.-MOD-2022-664042, US-MODERNATX, INC.-MOD-2022-664045, US-MODERNATX, INC.-MOD-2022-664056, US-MODERNATX, INC.-MOD-2022-664064 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-664063:Same reporter US-MODERNATX, INC.-MOD-2022-664049:Same reporter US-MODERNATX, INC.-MOD-2022-664042:Same reporter US-MODERNATX, INC.-MOD-2022-664045:Same reporter US-MODERNATX, INC.-MOD-2022-664056:Same reporter US-MODERNATX, INC.-MOD-2022-664064:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They gave the vaccine more than 12 hours post 1st puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They gave the vaccine more than 12 hours post 1st puncture) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 vaccination. No Medical History information was reported. On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 21-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They gave the vaccine more than 12 hours post 1st puncture). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They gave the vaccine more than 12 hours post 1st puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They gave the vaccine more than 12 hours post 1st puncture). No concomitant medications were reported. It was reported that, on 21-Oct-2022 (at 9:00-9:30 AM) nurse gave a Moderna COVID-19 bivalent booster vaccine from a vial which had been first punctured on 20-Oct-2022 at 10:20 AM. They gave the vaccine more than 12 hours post 1st puncture. Vial size reported was 2.5 milliliter. The vial was initially stored in refrigerator on 20-Oct-2022 at 17:03 PM. The vial was stored at room temperature post puncture, and it did not undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) was 23 hours and some minutes. No treatment details were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 17.10.2022
- Beginn
- 17.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Joint swelling
Symptomtext
Systemic: SWELLING AT ELBOW OF VACCINE ARM-Mild, Additional Details: PT NOTICED SWELLING IN HER LEFT ELBOW (VACCINATED ARM) APPROXIMATELY 1 HR AFTER VACCINES GIVEN. GAVE BOTH FLU AND COVID IN SAME LEFT ARM BY TECHNICIAN. DOUBLE CHECKED AND SITE IS APPROPRIATE (NOT CLOSE TO BURSA). PT EXPERIENCES NO PAIN AT INJECTION SITE, ANYWHERE ELSE ON ARM, NOT EVEN AT AREA OF SWELLING. SWELLING IS SOFT (IE WATER BLISTER) AND UNPAINFUL. PT LEFT PHARMACY FEELING FINE, FOLLOW UP PHONE CALL FINDS HER STILL NOT IN PAIN AND FULL USE OF ARM.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Joint swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Wrong product administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 25.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 21.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Wrong product administered
Symptomtext
Error: Wrong Vaccine/Product Administered-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tinnitus
Symptomtext
Tinnitus re-aggravated after the booster. I suspected Tinnitus previously arose after early COVID-19 vaccines (including original J&J shot back in April 2021). It came back this afternoon and reminded me of the whole thing. I also had a Moderna booster in December 2021, which elevated the Tinnitus again. Before it lasted for months. We'll see what happens this time. When it happened before, I went to various Drs. for assessment to make sure I had no ear damage, etc. All findings were negative. When I asked about possible cause being COVID-19 vaccine, there was no definitive answer. I feel pretty strongly about cause and effect evidence at this point. I have to simply trust it will go away with time. It is distracting.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- See note under the previous section about Tinnitus arising after original J&J COVID-19 vaccine and subsequent Moderna booster.
- Staat
- IA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 24.10.2022
- Impfdatum
- 24.10.2022
- Beginn
- 24.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient presented to the clinic with her husband to get a Moderna Bivalent vaccine and a flu shot. Reporting nurse realized she gave this patient both Moderna vaccines in each deltoid instead of 1 Moderna and 1 flu. Patient notified right after the injection was complete. Patient observed for 15 minutes without reaction. Patient will notify the office if she has side effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Codeine
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 21.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT. WE ARE JUST REPORTING ADMINISTRATION OF THE VACCINE AFTER RECCOMMENDED TIME ROOM TEMPERATUE. MODERNA MEDICAL TEAM VERIFIED THAT VACCINE WAS STILL EFFECTIVE , AND PT NOTIFIED FOR OF POTENTIAL FOR SITE INFECTION. NO ADVERSE EFFECT AT THIS TIME.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 18.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Error: Dose in Series Given Too Early-
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -